Organic, including symptomatic, mental disorders

F5_ORGANIC

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_DEMENTIA F5_ORGAMN F5_DELIRIUM F5_MENTORG F5_PERSBEHORG F5_UNSORG	44213
6. Filter based on genotype QC (FinnGen only)	38676

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	F5_ORGANIC
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_DEMENTIA\|F5_ORGAMN\|F5_DELIRIUM\|F5_MENTORG\|F5_PERSBEHORG\|F5_UNSORG
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Organic, including symptomatic, mental disorders based on the number of shared cases.

Similar with more cases:

Psychiatric diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	38676	17986	20690
Unadjusted period prevalence (%)	8.04	6.39	9.49
Median age at first event (years)	78.34	78.87	77.87

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
27515: Matched controls
193442

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.0

314.1

4070

15254

W19

ICD-10 Finland

Unspecified fall

2.2

311.2

3228

11102

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.9

310.1

5057

20521

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

3.7

309.1

1150

2282

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

4.3

307.7

1590

2707

L28

ICPC

Limited function/disability (L)

2.4

307.7

7771

27664

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

4.0

307.7

3230

6208

G31.0

ICD-10 Finland

Circumscribed brain atrophy

15.1

307.7

370

175

AXX01, ,

SPAT

4.3

307.7

2410

4187

SPAT1254

SPAT

Administration of medicine

2.6

307.7

5731

17796

F02.39*G20

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

248.6

307.7

656

G30.1

ICD-10 Finland

Alzheimer disease with late onset

104.9

307.7

8164

775

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

4.5

307.7

2138

3580

S01.0

ICD-10 Finland

Open wound of scalp

2.5

307.7

2938

8816

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

102.7

307.7

3763

298

F01.9

ICD-10 Finland

Vascular dementia, unspecified

62.3

307.7

1301

154

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

462.6

307.7

1014

N06AB04

ATC

citalopram; systemic

1.9

307.7

5750

23638

SPAT1301

SPAT

No procedures

1.9

307.7

9668

43720

R1250

NOMESCO Finland

Evaluation of functional capability

4.6

307.7

1028

1606

F06.7

ICD-10 Finland

Mild cognitive disorder

26.6

307.7

3544

1069

N06DA04

ATC

galantamine; oral

273.3

307.7

2795

A06AD11

ATC

lactulose; oral

2.2

307.7

5698

20847

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

21.2

307.7

463

156

S72.0

ICD-10 Finland

Fracture of neck of femur

3.1

307.7

1818

4266

P70

ICPC

Dementia

42.9

307.7

2405

431

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

307.7

4757

18026

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

7.2

307.7

792

797

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

103.7

307.7

2739

206

G20

ICD-10 Finland

Parkinson disease

4.3

307.7

1766

3023

G30

ICD-10 Finland

Alzheimer disease

134.6

307.7

1121

A28

ICPC

Limited function/disability NOS

3.5

307.7

9646

25711

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

307.7

5881

19000

N05AH04

ATC

quetiapine; oral

4.6

307.7

7076

13461

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

307.7

11449

45674

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

3.2

307.7

2284

5357

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.3

307.7

1742

3906

F0019, G301,

ICD-10 Finland

+∞

307.7

417

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.1

307.7

1384

2442

G30.0

ICD-10 Finland

Alzheimer disease with early onset

162.0

307.7

978

SPAT1053

SPAT

Memory test

4.7

307.7

9152

18706

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.8

307.7

2356

6219

N87

ICPC

Parkinsonism

6.1

307.7

952

1122

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.6

307.7

3468

10053

XA800

NOMESCO Finland

Neuropsychological investigation

5.1

307.7

1753

2532

WYA20

NOMESCO Finland

Home visit

8.2

307.7

1079

959

G30.8

ICD-10 Finland

Other Alzheimer disease

84.5

307.7

2494

228

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.1

307.7

1858

4433

N06AB10

ATC

escitalopram; oral

2.1

307.7

4610

16911

F03

ICD-10 Finland

Unspecified dementia

50.7

307.7

4866

817

N06AX11

ATC

mirtazapine; oral

2.1

307.7

10191

42708

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

6.0

307.7

682

818

N05AD01

ATC

haloperidol; systemic

4.8

307.7

1549

2359

SPAT1304

SPAT

Counselling and guidance related to ageing

2.6

307.7

3208

9379

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

138.5

307.7

273

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

307.7

2270

5587

N05AX08

ATC

risperidone; systemic

12.9

307.7

6594

4614

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.7

307.7

1138

1447

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

307.7

9358

40895

R41.3

ICD-10 Finland

Other amnesia

5.9

307.7

1797

2252

A04

ICPC

Weakness/tiredness general

2.2

307.7

5309

18701

OAB76

NOMESCO Finland

General guidance on nutrition and food

49.8

307.7

308

AA1AD

NOMESCO Finland

CT of head and brain

2.7

307.7

12060

43427

N03AG01

ATC

valproic acid; systemic, rectal

5.0

307.7

2558

3885

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

229.4

307.7

4135

149

SPAT1245

SPAT

Provision of support and information to patient’s family members

5.5

307.7

2498

3461

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.8

307.7

8807

28093

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.5

307.7

2954

8813

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

29.6

307.7

448

108

AXX01

NOMESCO Finland

Memory assessment

15.5

307.7

567

262

N06DA02

ATC

donepezil; oral

193.1

307.7

8634

457

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.8

307.7

2062

5506

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.1

307.7

4270

8315

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

8.4

307.7

7966

8974

I95.1

ICD-10 Finland

Orthostatic hypotension

3.3

307.7

1910

4226

N06AX26

ATC

vortioxetine; oral

3.2

307.7

1954

4446

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

39.3

307.7

714

131

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

299.7

307.7

625

F05.1

ICD-10 Finland

Delirium superimposed on dementia

689.1

307.7

670

N05AH03

ATC

olanzapine; systemic

5.2

307.7

2468

3603

S06.0

ICD-10 Finland

Concussion

2.3

307.7

3318

10714

SPAT1234

SPAT

Support of social functional capacity

4.6

307.7

2746

4598

SPAT1229

SPAT

Assessment of need for aid

2.4

307.7

2909

8920

F01.2

ICD-10 Finland

Subcortical vascular dementia

37.4

307.7

342

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

+∞

307.7

3605

F05.8

ICD-10 Finland

Other delirium

158.4

307.7

936

N02AA05

ATC

oxycodone; systemic

1.9

307.7

6513

27219

N06DX01

ATC

memantine; oral

365.0

307.7

10707

337

N05BA04

ATC

oxazepam; oral

2.4

307.7

8648

31139

F06.0

ICD-10 Finland

Organic hallucinosis

124.4

307.7

263

U04

ICPC

Incontinence urine

2.9

307.7

2542

6540

N06DA03

ATC

rivastigmine; oral, transdermal

223.0

307.7

6085

246

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

307.7

3106

9288

P20

ICPC

Memory disturbance

10.1

307.7

12444

14605

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

239.1

307.7

336

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

371.1

307.7

417

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

48.9

307.7

364

SPAT1101

SPAT

Orthostatic test

3.0

307.7

1834

4441

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.7

307.7

6317

19432

R41.0

ICD-10 Finland

Disorientation, unspecified

7.5

307.7

2197

2210

R53

ICD-10 Finland

Malaise and fatigue

2.5

307.7

8729

30511

TAB00

NOMESCO Finland

Lumbar puncture

5.2

307.7

1853

2648

F05.9

ICD-10 Finland

Delirium, unspecified

167.9

307.7

3116

147

N05BA06

ATC

lorazepam; systemic, sublingual

3.2

307.7

2060

4741

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

959.9

307.7

664

SPAT1216

SPAT

Assessment of functional ability

2.9

307.7

6988

20261

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

142.4

307.7

340

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

6.8

304.2

563

595

R42

ICD-10 Finland

Dizziness and giddiness

1.7

303.9

7372

33731

OAB48

NOMESCO Finland

Lifestyle advice and guidance

20.3

301.1

294

103

R55

ICD-10 Finland

Syncope and collapse

2.0

298.6

3908

14678

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.0

293.3

3951

14987

A29

ICPC

General symptom/complaint other

1.9

292.2

4327

16963

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

284.4

5168

21644

SPAT1172

SPAT

Guidance concerning hydration

3.7

284.1

1055

2089

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.5

280.4

1111

2301

N04BD01

ATC

selegiline; oral

5.0

279.0

695

998

SPAT1252

SPAT

Overall medication plan or its review

2.3

278.7

2409

7651

F00

ICD-10 Finland

Dementia in Alzheimer disease

45.0

272.8

216

F01.3

ICD-10 Finland

Mixed cortical and subcortical vascular dementia

62.5

269.8

203

C03CA01

ATC

furosemide; systemic

1.6

264.2

10998

57288

F06.32

ICD-10 Finland

Organic depression

36.5

255.5

211

N05AX12

ATC

aripiprazole; systemic

4.0

252.4

833

1512

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

243.6

2254

7356

F009, G309,

ICD-10 Finland

1824.7

237.0

264

Z2445

NOMESCO Finland

Psychologist

3.6

235.4

903

1827

T90.5

ICD-10 Finland

Sequelae of intracranial injury

5.9

233.3

488

590

N06AB06

ATC

sertraline; oral

2.1

232.3

2539

8860

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

3.9

230.4

773

1420

P29

ICPC

Psychological sympt/compl other

2.7

222.5

1413

3862

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

216.2

1823

5705

N02BE01

ATC

paracetamol; systemic, rectal

1.8

216.1

23800

151454

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

213.3

2960

11257

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

213.1

3808

15726

N03AX09

ATC

lamotrigine; oral

3.1

212.7

1021

2386

E86

ICD-10 Finland

Volume depletion

3.1

212.5

996

2294

F01

ICD-10 Finland

Vascular dementia

20.6

210.4

204

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

6.5

209.0

400

439

N03AX14

ATC

levetiracetam; systemic

3.1

208.3

991

2303

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.1

207.9

2346

8272

N05AA02

ATC

levomepromazine; systemic

2.8

207.6

1198

3110

OAB43, ,

SPAT

0.3

206.0

605

13653

F07.2

ICD-10 Finland

Postconcussional syndrome

81.6

205.7

150

N30.0

ICD-10 Finland

Acute cystitis

1.7

205.0

4609

20329

SPAT1360

SPAT

Extensive global examination

2.1

204.7

2172

7476

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.5

204.2

802

1648

SPAT1167

SPAT

Insertion of urinary catheter

2.7

204.1

1252

3358

N27

ICPC

Fear of neurological disease other

3.7

203.4

723

1385

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.6

203.1

769

1541

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.8

199.3

705

1346

N04BD02

ATC

rasagiline; oral

6.4

199.0

386

430

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

198.9

8104

41313

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.2

198.8

894

2006

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.5

198.7

442

569

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

198.1

4164

18005

R44.1

ICD-10 Finland

Visual hallucinations

8.8

197.6

297

240

SPAT1263

SPAT

Sampling

1.5

197.5

10760

58292

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

2.6

197.1

1314

3677

F22.0

ICD-10 Finland

Delusional disorder

4.7

194.3

517

787

N06AX16

ATC

venlafaxine; oral

1.9

191.9

2950

11588

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

191.0

7974

40790

R5110, ,

SPAT

1.9

190.2

2863

11166

Z29

ICPC

Social problem NOS

3.9

190.1

648

1204

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.5

188.4

736

1506

G04BD12

ATC

mirabegron; oral

1.7

188.0

3982

17232

N05AH02

ATC

clozapine; systemic

5.2

188.0

447

614

R33

ICD-10 Finland

Retention of urine

1.9

185.5

2892

11405

Z75.5

ICD-10 Finland

Holiday relief care

6.3

184.9

363

410

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.8

179.1

3584

15244

SPAT1139

SPAT

Nutrition survey

2.7

177.3

1048

2753

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

707.7

177.0

200

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

176.9

3547

15090

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

176.7

2666

10393

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

4.7

176.6

472

721

193

Kela drug reimbursment

Rasagiline

7.2

176.1

308

304

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.8

176.1

608

1140

N05AD03

ATC

melperone; systemic

4.5

174.1

481

756

F01.10

ICD-10 Finland

Multi-infarct dementia without additional symptoms

42.7

173.8

139

N03AE01

ATC

clonazepam; systemic

2.2

173.5

1594

5163

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.3

173.5

744

1619

N05CD07

ATC

temazepam; oral

1.7

173.4

3776

16435

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

172.5

2693

10610

C10AA01

ATC

simvastatin; oral

1.4

171.7

13253

76048

C03DA05

ATC

finerenone; oral

24.5

170.4

156

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.0

170.3

551

984

AA1AD, ,

SPAT

6.0

170.0

350

416

F21, ,

ICPC

5.9

169.4

355

430

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

3.3

169.0

716

1546

N05BA01

ATC

diazepam; systemic, rectal

1.7

167.2

3504

15077

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

166.5

4103

18443

R44.3

ICD-10 Finland

Hallucinations, unspecified

8.4

166.3

257

216

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

272.1

165.8

193

N03AF02

ATC

oxcarbazepine; oral

2.8

163.1

936

2419

3071, ,

Kela drug reimbursment

+∞

163.1

180

G72.8

ICD-10 Finland

Other specified myopathies

3.5

162.6

636

1302

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

161.5

2134

7942

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

159.6

698

1538

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.5

159.4

616

1251

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

324.5

159.2

184

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.7

158.1

575

1119

N05AN01

ATC

lithium; oral

3.6

158.0

598

1197

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.2

157.8

1437

4633

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

155.0

1846

6615

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

1267.0

154.5

173

N04AA02

ATC

biperiden; systemic

3.6

154.3

568

1115

S70.0

ICD-10 Finland

Contusion of hip

2.4

154.2

1248

3822

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.9

152.6

2425

9589

N29

ICPC

Neurological sympt/complt other

3.2

151.9

667

1473

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

409.5

151.8

174

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.9

151.8

2072

7792

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.9

150.4

2135

8136

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.7

148.7

901

2396

F06.4

ICD-10 Finland

Organic anxiety disorder

40.3

148.4

120

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.4

147.3

594

1241

IHZ08, ,

SPAT

8.0

147.0

237

211

P99

ICPC

Psychological disorders other

3.3

146.9

631

1374

G04CA02

ATC

tamsulosin; oral

1.4

146.2

7867

41867

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

200.0

142.9

169

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.7

141.9

841

2210

N05AB03

ATC

perphenazine; systemic, rectal

2.7

141.8

880

2369

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

5.4

137.8

314

414

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

137.6

1488

5136

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

137.1

2621

10945

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.2

137.1

1235

3960

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

136.8

724

1788

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.6

136.2

513

1023

SPAT1262

SPAT

Handing over of treatment supplies

1.5

135.8

4885

23905

ZY000

NOMESCO Finland

Hospital inpatient

5.1

135.2

325

451

N04BC04

ATC

ropinirole; oral

4.0

133.8

425

748

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

186.6

133.1

158

S06.3

ICD-10 Finland

Focal brain injury

3.7

131.1

468

899

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

522.4

130.1

148

G04CB01

ATC

finasteride; oral

1.6

129.1

3835

17949

P15

ICPC

Chronic alcohol abuse

2.8

129.0

708

1784

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

137.9

128.7

156

N28

ICPC

Limited function/disability (N)

3.1

128.7

600

1375

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

25.0

128.6

117

N05CF01

ATC

zopiclone; oral

1.4

128.6

8782

48520

N06AX21

ATC

duloxetine; oral

1.7

127.8

2623

11165

SPAT1251

SPAT

Organisation of medication

2.3

126.3

1037

3192

F10.24

ICD-10 Finland

Alcohol depence active use

3.9

126.1

418

760

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

125.7

2135

8597

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

124.4

736

1932

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

14.0

123.9

141

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.5

123.2

475

963

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.6

123.1

3550

36303

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

3.0

122.6

608

1446

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

121.2

7493

40598

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.3

120.9

354

584

183

Kela drug reimbursment

Lamotrigin and topiramate

5.5

120.7

267

342

F0009, G300,

ICD-10 Finland

+∞

120.5

133

F0014, G301,

ICD-10 Finland

479.7

119.3

136

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

118.4

5795

53566

S00.0

ICD-10 Finland

Superficial injury of scalp

2.7

118.3

734

1975

N03AX18

ATC

lacosamide; systemic

5.2

118.2

278

378

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.4

118.2

336

541

ICB01, ,

SPAT

5.9

117.8

246

297

SPAT1260

SPAT

Consultation of another employee

1.5

114.2

4555

22683

A27

ICPC

Fear of other disease NOS

2.0

112.3

1438

5273

R11

ICD-10 Finland

Nausea and vomiting

1.7

112.3

2216

9314

A10AB05

ATC

insulin aspart; parenteral

1.8

111.4

2007

8214

F06.30

ICD-10 Finland

Organic manic syndrome

+∞

111.4

123

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

54.5

110.7

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

109.0

5001

25575

IHA21

NOMESCO Finland

Mini-intervention for hazardous and harmful alcohol use

24.3

109.0

100

N17

ICPC

Vertigo/dizziness

1.5

108.9

3572

17045

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

108.6

6420

34389

K90

ICPC

Stroke/cerebrovascular accident

2.2

108.4

984

3161

N04BX02

ATC

entacapone; oral

7.1

108.2

191

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.7

107.9

390

756

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

107.4

1064

3543

G40

ICD-10 Finland

Epilepsy

4.7

107.1

285

434

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

106.8

3282

15428

F01.1

ICD-10 Finland

Multi-infarct dementia

430.0

106.7

122

W0A10

NOMESCO Finland

Mapping of psychosocial situation

12.2

106.6

130

R25.1

ICD-10 Finland

Tremor, unspecified

2.3

106.6

930

2938

SPAT1240

SPAT

Therapeutic discussion

1.8

106.4

1739

6908

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.5

106.3

235

301

SPAT1050

SPAT

Extensive neurological examination

2.8

106.3

611

1579

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.0

106.0

532

1274

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

106.0

2666

11944

H02AA02

ATC

fludrocortisone; oral

4.3

105.5

312

519

N03AF01

ATC

carbamazepine; oral, rectal

2.0

105.3

1348

4941

J01EA01

ATC

trimethoprim; systemic

1.4

105.0

6281

33676

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.2

105.0

473

1061

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.8

105.0

270

399

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

104.6

9372

53620

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

4.2

104.6

315

532

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

16.7

103.7

109

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

103.0

3297

15632

F20.9

ICD-10 Finland

Schizophrenia, unspecified

3.2

102.7

467

1054

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

+∞

102.3

113

N05AF03

ATC

chlorprothixene; systemic

2.7

102.1

592

1537

F09

ICD-10 Finland

Unspecified organic or symptomatic mental disorder

213.1

101.9

120

130

Kela drug reimbursment

Malignant tumour

0.5

101.9

1011

13821

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

101.6

10653

62300

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

101.3

782

2339

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

408.7

101.3

116

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

8.1

100.6

159

138

K59.0

ICD-10 Finland

Constipation

1.8

100.4

1650

6563

A10AE04

ATC

insulin glargine; parenteral

1.6

100.2

2562

11516

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

99.9

505

1214

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

99.6

4433

22493

B01AA03

ATC

warfarin; systemic

1.4

99.4

6063

32565

W06

ICD-10 Finland

Fall involving bed

3.9

99.2

324

583

SPAT1125

SPAT

Stoma care and guidance

2.7

98.4

577

1507

F01.0

ICD-10 Finland

Vascular dementia of acute onset

121.0

98.1

120

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

97.9

1711

6932

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

97.6

3861

19131

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

97.1

4211

21247

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

264.7

97.1

113

R32

ICD-10 Finland

Unspecified urinary incontinence

2.3

96.7

842

2656

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

96.6

2715

12480

R1250, ,

SPAT

2.3

96.5

844

2668

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.6

96.3

261

404

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

96.2

5450

28878

AA1CG, ,

SPAT

4.2

95.3

290

494

J01CA08

ATC

pivmecillinam; oral

1.3

94.9

8396

47766

N88

ICPC

Epilepsy

5.2

94.3

220

297

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

94.1

1102

3909

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

12.4

94.1

114

N07BB01

ATC

disulfiram; oral

2.2

94.0

866

2798

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.3

93.8

387

821

S06.2

ICD-10 Finland

Diffuse brain injury

3.9

93.5

314

577

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

93.2

1650

6708

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

3.1

93.1

439

1013

F01.80

ICD-10 Finland

Other specified vascular dementia without additional symptoms

40.7

92.8

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

373.1

92.3

106

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.4

91.8

676

1978

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

91.8

7092

39483

F02.39

ICD-10 Finland

Dementia in Parkinson's disease without information on additional symptoms

191.1

91.2

108

P72

ICPC

Schizophrenia

3.2

91.2

399

879

UKC02

NOMESCO Finland

Cystoscopy

1.4

91.0

4850

25391

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

91.0

1301

4947

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.1

90.6

281

486

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.4

90.2

254

406

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

90.2

1803

7588

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.5

90.0

350

714

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

3.3

89.7

387

845

G35

ICD-10 Finland

Multiple sclerosis

3.7

89.1

321

621

H02AB02

ATC

dexamethasone; systemic

0.6

88.4

1239

15273

SPAT1307

SPAT

Psychosocial counselling and guidance

2.2

87.9

818

2653

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

5.0

87.9

214

301

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.2

87.9

803

2585

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.4

87.9

355

743

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.5

87.8

338

685

30920

ICD-8 Finland

Mental disorders not specified as psychotic associated with physical conditions, Brain trauma

+∞

86.9

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.7

86.9

143

131

K08.3

ICD-10 Finland

Retained dental root

1.6

86.6

2030

8911

EB4VA, ,

NOMESCO Finland

0.6

86.5

1219

15013

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

3.5

86.4

328

658

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

86.3

4829

25470

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

86.1

9072

52728

G04BD08

ATC

solifenacin; oral

1.7

85.9

1885

8132

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

85.8

6967

39004

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.3

85.3

361

779

F60.9

ICD-10 Finland

Personality disorder, unspecified

4.3

85.1

248

408

IGV01

NOMESCO Finland

Psychiatric network contact

5.3

84.8

197

265

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.3

84.8

356

764

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

84.4

958

3359

WX212

NOMESCO Finland

Femoral plexus blockade

2.3

84.3

731

2302

XF606, ,

SPAT

3.8

84.1

292

550

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

84.1

6774

37855

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

84.1

1334

5242

S09.9

ICD-10 Finland

Unspecified injury of head

2.8

83.8

453

1132

A01

ICPC

Pain general/multiple sites

1.6

83.4

2542

11884

F0029, G308,

ICD-10 Finland

+∞

83.3

D12

ICPC

Constipation

1.9

82.8

1114

4148

F001, G301,

ICD-10 Finland

226.7

82.8

R35

ICD-10 Finland

Polyuria

1.6

82.3

1965

8662

N99

ICPC

Neurological disease other

3.1

82.3

390

903

N06AB03

ATC

fluoxetine; oral

1.5

81.6

2568

12089

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.5

81.5

226

357

G04BD07

ATC

tolterodine; oral

1.8

80.9

1376

5523

K91

ICPC

Cerebrovascular disease

2.7

80.7

468

1215

C07AB07

ATC

bisoprolol; oral

1.3

80.6

14087

87171

Z51.5

ICD-10 Finland

Palliative care

1.5

80.6

2726

13035

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

80.6

3373

16847

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

634.3

79.6

SPAT1310

SPAT

Counselling related to known health issue

1.3

79.3

7543

43101

P28

ICPC

Limited function/disability (P)

4.5

79.3

216

336

P05

ICPC

Senility, feeling/behaving old

4.9

79.1

197

283

ZYB04, ,

SPAT

6.0

78.9

161

190

N05BE01

ATC

buspirone; oral

2.3

78.7

651

2008

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

4.0

77.4

246

434

Z01.9

ICD-10 Finland

Special examination, unspecified

1.7

77.3

1463

6055

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.6

77.2

284

558

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.8

77.1

267

502

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

5.4

76.7

174

229

S22.3

ICD-10 Finland

Fracture of rib

1.6

76.6

1826

8041

OAA80, ,

SPAT

0.2

76.6

145

4269

OAA67, ,

SPAT

0.4

76.4

516

8123

Z28

ICPC

Limited function/disability (Z)

5.0

76.2

188

268

XF606

NOMESCO Finland

Ortostatic test

3.4

76.1

303

628

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.4

75.9

306

640

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.9

75.8

387

936

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.7

75.6

5639

49632

109

Kela drug reimbursment

Multiple sclerosis

4.5

75.6

211

335

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.8

75.6

425

1085

Y94.0

ICD-10 Finland

Accident at home

2.5

75.5

533

1529

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.2

75.0

729

2406

Z03

ICPC

Housing/neighbourhood problem

4.4

74.8

214

347

N05AF05

ATC

zuclopenthixol; systemic

3.8

74.7

253

468

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

74.5

771

2609

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

74.5

945

3447

E0000UV, ,

ATC

1.3

74.4

9613

57088

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.9

74.0

245

446

S97

ICPC

Chronic ulcer skin

1.6

73.9

1867

8341

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

3.3

73.8

312

673

J01MA02

ATC

ciprofloxacin; systemic

1.3

73.7

10124

60560

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.9

73.5

374

903

N86

ICPC

Multiple sclerosis

4.9

73.4

184

266

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

3.9

73.3

240

433

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.0

73.2

369

886

N19

ICPC

Speech disorder

2.8

73.2

408

1037

F01.39

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without information on additional symptoms

105.8

72.9

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.5

72.6

281

572

B01AC04

ATC

clopidogrel; oral

1.4

72.4

4970

27007

Z2446

NOMESCO Finland

Social worker

1.7

72.0

1376

5709

P03

ICPC

Feeling depressed

1.7

72.0

1448

6095

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

71.8

1177

4668

G41.9

ICD-10 Finland

Status epilepticus, unspecified

4.4

71.8

205

332

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

71.7

779

2686

M05BX06

ATC

romosozumab; parenteral

26.5

71.5

WYA20, ,

SPAT

3.5

71.0

268

536

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4.2

70.8

209

348

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

70.3

9107

53993

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

5.0

70.3

170

238

OAB48, ,

SPAT

0.5

70.1

535

8051

N05BA09

ATC

clobazam; oral

5.3

70.0

160

212

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

3.9

70.0

228

410

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

2.2

70.0

649

2102

F0011, G301,

ICD-10 Finland

556.4

69.7

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

69.5

6911

39583

SPAT1138

SPAT

Guidance concerning bowel function

2.7

69.2

417

1105

F01.8

ICD-10 Finland

Other vascular dementia

77.6

69.0

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

8.3

68.8

107

N06AX03

ATC

mianserin; oral

1.8

68.4

1135

4518

N04BC09

ATC

rotigotine; transdermal

5.0

68.3

168

239

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

144.5

68.1

N04BC05

ATC

pramipexole; oral

1.6

68.1

1934

8878

R44.0

ICD-10 Finland

Auditory hallucinations

5.3

67.5

154

204

SPAT1014

SPAT

Treatment of eyes

2.4

67.3

502

1478

OAA65, ,

SPAT

0.4

67.2

459

7204

S01.8

ICD-10 Finland

Open wound of other parts of head

2.6

67.0

433

1190

P76

ICPC

Depressive disorder

1.9

66.6

983

3771

G21.9

ICD-10 Finland

Secondary parkinsonism, unspecified

5.6

66.3

145

184

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

7.9

66.1

107

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.9

66.1

164

235

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.6

66.1

245

484

AA1BG, ,

SPAT

2.6

66.0

428

1178

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

65.9

748

2621

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

65.9

1585

6990

R63.4

ICD-10 Finland

Abnormal weight loss

1.8

65.7

1112

4452

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

65.6

9010

53673

L75

ICPC

Fracture: femur

2.6

65.4

422

1159

N03AB02

ATC

phenytoin; systemic

2.9

65.3

340

832

P18

ICPC

Medication abuse

4.7

65.1

171

258

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.7

65.1

171

258

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

181.2

65.0

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.1

64.8

648

2163

N80

ICPC

Head injury other

2.3

64.8

519

1579

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.2

64.7

288

642

F07.0

ICD-10 Finland

Organic personality disorder

513.9

64.3

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.3

64.2

269

577

P19

ICPC

Drug abuse

4.7

64.1

168

253

N05AC02

ATC

thioridazine; oral

2.5

63.5

421

1172

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

63.2

10313

62606

Z72.1

ICD-10 Finland

Alcohol use

3.0

63.2

303

707

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

63.0

17596

113380

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

5.5

62.7

139

179

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.7

62.7

1236

5171

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.3

62.6

520

1607

R45.1

ICD-10 Finland

Restlessness and agitation

7.7

62.3

102

ZY010

NOMESCO Finland

Hospital outpatient

1.9

62.2

855

3204

Z60.8

ICD-10 Finland

Other problems related to social environment

6.3

61.9

120

134

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

61.8

1428

6231

A46

ICD-10 Finland

Erysipelas

1.4

61.7

3997

21460

A10BB12

ATC

glimepiride; oral

1.5

61.7

1990

9392

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

5.2

61.6

145

198

3079, ,

Kela drug reimbursment

+∞

61.6

IGP01

NOMESCO Finland

Psychiatric family contact

5.4

61.4

138

180

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.8

61.1

328

817

F06.39

ICD-10 Finland

Organic mood syndrome UNS

130.4

61.1

J01DB01

ATC

cefalexin; oral

1.3

60.8

20175

132292

M01AH05

ATC

etoricoxib; oral

0.8

60.7

10871

86664

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

4.7

60.2

159

241

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

11.7

60.2

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

60.1

1880

8814

N06AX12

ATC

bupropion; oral

1.9

60.0

888

3409

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

2.4

59.8

469

1413

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.2

59.7

12997

81262

A86

ICD-10 Finland

Unspecified viral encephalitis

4.7

59.6

154

229

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

59.6

1908

8990

F31

ICD-10 Finland

Bipolar affective disorder

3.5

59.5

228

461

SPAT1284

SPAT

Extensive health certificate

2.2

59.3

553

1795

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.6

59.3

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

3.7

59.3

206

389

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.7

58.8

154

232

Z08

ICPC

Social welfare problem

3.0

58.8

293

700

R60.0

ICD-10 Finland

Localized oedema

1.4

58.7

3392

17870

R1210, ,

SPAT

4.0

58.4

184

323

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.3

58.3

247

534

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.8

58.2

1031

4182

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

58.2

531

1709

F00, F03,

ICD-10 Finland

+∞

57.9

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

2.4

57.6

428

1258

N18

ICPC

Paralysis/weakness

2.1

57.3

561

1857

C09AA05

ATC

ramipril; oral

1.3

57.3

7092

41562

B01AC07

ATC

dipyridamole; systemic

1.6

57.3

1357

5956

R40.2

ICD-10 Finland

Coma, unspecified

3.1

57.1

265

607

A04AA02

ATC

granisetron; systemic, transdermal

0.5

57.0

539

7538

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

56.9

4241

23234

SPAT1325

SPAT

Vaccination

1.2

56.8

8770

52721

C01DA14

ATC

isosorbide mononitrate; oral

1.3

56.7

5018

28162

ZXD05

NOMESCO Finland

Urgent procedure

1.3

56.7

6817

39801

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.4

56.7

442

1329

P27

ICPC

Fear of mental disorder

3.3

56.5

235

502

R50.9

ICD-10 Finland

Fever, unspecified

1.4

56.3

3496

18622

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

55.9

2082

10120

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

55.8

7442

43970

G91.0

ICD-10 Finland

Communicating hydrocephalus

4.1

55.5

171

295

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.1

55.3

601

2072

ZXY02

NOMESCO Finland

Neuropsychologist

4.9

55.3

138

199

N05BA12

ATC

alprazolam; oral

1.5

55.3

2071

10076

XKD00

NOMESCO Finland

Uroflowmetry

1.3

55.3

4630

25777

R4120, ,

SPAT

2.6

55.2

360

994

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.4

55.2

310

5262

I95.9

ICD-10 Finland

Hypotension, unspecified

2.3

55.1

452

1390

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

3.5

55.0

213

434

R54

ICD-10 Finland

Senility

3.9

54.4

179

325

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

54.1

5152

29173

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.6

54.1

197

385

N06AA09

ATC

amitriptyline; systemic

1.5

54.0

2232

11071

N03AX16

ATC

[U] pregabalin

1.3

53.9

5300

30138

SPAT1127

SPAT

Enema

3.1

53.8

246

558

F32

ICD-10 Finland

Depressive episode

1.9

53.8

800

3076

N05AA01

ATC

chlorpromazine; systemic, rectal

2.9

53.8

280

686

XF600, ,

SPAT

1.7

53.8

1024

4240

GD1AA, ,

SPAT

0.6

53.7

1279

13895

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

53.6

572

1959

F02.30

ICD-10 Finland

Dementia in Parkinson's disease without additional symptoms

150.3

53.4

N05BA02

ATC

chlordiazepoxide; systemic

2.1

53.3

556

1888

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

10.4

53.2

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

53.0

1350

6031

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.7

52.9

188

361

F23.90

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

7.2

52.6

L76

ICPC

Fracture: other

1.8

52.5

818

3191

EBA00

NOMESCO Finland

Extraction of tooth

1.2

52.2

7799

46603

A10BH05

ATC

linagliptin; oral

1.6

52.1

1455

6644

S28

ICPC

Limited function/disability (S)

3.2

52.0

228

504

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

51.9

905

3653

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

3.2

51.9

225

494

U05

ICPC

Urination problems other

1.6

51.8

1451

6628

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

51.7

752

2871

Z00.0

ICD-10 Finland

General medical examination

1.3

51.4

4506

25215

HA1RA, ,

SPAT

0.3

51.3

177

3748

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.5

51.1

195

394

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

51.0

5186

29591

N03AX12

ATC

[U] gabapentin; oral

1.3

51.0

3595

19503

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.6

50.9

332

917

SPAT1243

SPAT

Psychiatric/psychological examination

2.6

50.9

335

930

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

2.8

50.8

284

724

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.6

50.8

323

881

R45.5

ICD-10 Finland

Hostility

23.6

50.7

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

9.9

50.7

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

+∞

50.7

W10

ICD-10 Finland

Fall on and from stairs and steps

1.6

50.7

1197

5248

SPAT1285

SPAT

Provision of consultation response

1.6

50.7

1214

5342

P98

ICPC

Psychosis NOS/other

4.4

50.6

142

227

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.6

50.6

1147

4976

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

3.7

50.5

179

343

G04CB02

ATC

dutasteride; oral

1.4

50.4

2242

11265

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

50.3

6904

40826

P16

ICPC

Acute alcohol abuse

2.6

50.1

308

826

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.8

49.9

172

323

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

3.4

49.6

202

426

G04BD09

ATC

trospium; oral

1.9

49.6

645

2373

OAB95, ,

SPAT

0.3

49.4

119

3045

TQW40, ,

SPAT

0.6

49.2

1149

12546

Z10.0

ICD-10 Finland

Occupational health examination

0.4

49.1

216

4076

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

49.0

1322

5986

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.3

49.0

422

1326

D21

ICPC

Swallowing problem

2.2

48.8

427

1351

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.8

48.8

271

689

N06AA12

ATC

doxepin; systemic

1.6

48.7

1222

5438

R51.80

ICD-10 Finland

Headache

1.4

48.6

2825

14863

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

2.6

48.6

308

839

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

48.5

2046

10177

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.6

48.5

298

799

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

48.5

1093

4735

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

3.7

48.3

172

331

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.4

48.2

306

4946

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

6.5

48.1

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.4

48.0

2439

12544

Z01.8

ICD-10 Finland

Other specified special examinations

1.3

47.9

5180

29750

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

47.9

1142

5018

SPAT1281

SPAT

Other administrative function

1.5

47.8

1699

8173

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

47.7

2035

10142

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.0

47.7

554

1958

L03AB07

ATC

interferon beta-1a; parenteral

5.4

47.6

107

140

C07AB02

ATC

metoprolol; systemic

1.3

47.5

5622

32640

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

47.4

955

4015

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.5

47.3

1512

7110

IEY08

NOMESCO Finland

Psychiatric coaching, domestic and community skills

6.6

47.3

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.8

47.1

3776

33320

T68

ICD-10 Finland

Hypothermia

3.9

47.0

156

285

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

47.0

1188

5296

N03AX11

ATC

topiramate; oral

2.4

47.0

349

1027

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

47.0

2200

11154

Z43.5

ICD-10 Finland

Attention to cystostomy

3.1

46.9

218

500

N06AX05

ATC

trazodone; oral

2.1

46.9

458

1516

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

4.5

46.9

130

206

E87.6

ICD-10 Finland

Hypokalaemia

1.7

46.8

880

3630

SPAT1104

SPAT

Monitoring of emergency patient

1.5

46.8

1531

7236

N04BB01

ATC

amantadine; oral

2.3

46.7

370

1121

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

46.7

2972

27078

SPAT1255

SPAT

Intravenous administration of medicine

1.5

46.7

1587

7562

U08

ICPC

Urinary retention

1.9

46.6

623

2313

XF400

NOMESCO Finland

ECG with 12 standard connections

1.3

46.6

4027

22459

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

6.1

46.4

108

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

5.7

46.2

121

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

46.2

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

4.2

46.1

136

227

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.8

46.0

3436

30618

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

10.5

45.9

F01.23

ICD-10 Finland

Subcortical vascular dementia other additional symptoms, mainly depression

60.4

45.8

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

6.1

45.7

105

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

45.6

2366

12210

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

5.3

45.5

105

141

K92.0

ICD-10 Finland

Haematemesis

1.9

45.4

615

2294

SPAT1097

SPAT

Recording of ECG

1.3

45.4

3708

20514

ICC03

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric ward

6.9

45.1

SPAT1244

SPAT

Occupational therapy

2.7

45.0

263

687

A10BA02

ATC

metformin; oral

1.2

44.8

7499

45193

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.6

44.7

1066

4684

A10AE05

ATC

insulin detemir; parenteral

1.6

44.5

1140

5097

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

44.4

863

3593

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.9

44.4

563

2054

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.2

44.3

133

225

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

4.3

44.3

127

207

S20.2

ICD-10 Finland

Contusion of thorax

1.6

44.3

1125

5020

F61.0

ICD-10 Finland

Mixed personality disorders

2.8

44.2

246

626

L01BC06

ATC

capecitabine; oral

0.4

44.2

283

4561

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

44.2

6184

36550

M03BX01

ATC

baclofen; systemic

2.2

44.1

395

1262

P01

ICPC

Feeling anxious/nervous/tense

1.5

44.0

1415

6661

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

44.0

555

7106

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.6

43.7

278

759

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

2.2

43.7

391

1249

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

351.2

43.6

F34.1

ICD-10 Finland

Dysthymia

1.9

43.6

574

2121

N05AL01

ATC

sulpiride; systemic

2.4

43.5

332

989

F0024, G308,

ICD-10 Finland

+∞

43.4

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.6

43.4

117

181

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

43.3

4594

26280

AA400

NOMESCO Finland

Electroconvulsive therapy

3.5

43.2

163

327

XA400

NOMESCO Finland

EEG

3.5

43.1

162

324

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.3

43.0

126

209

K92.1

ICD-10 Finland

Melaena

1.5

42.9

1452

6909

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

2.2

42.9

397

1286

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

2.7

42.8

250

653

F02.32

ICD-10 Finland

Dementia in Parkinson's disease other additional symptoms, mainly hallucinations

119.7

41.9

A99

ICPC

Disease/condition unspecnature/site

1.4

41.9

2441

12830

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.3

41.8

2934

15868

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

4.4

41.8

117

187

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

337.1

41.8

S32.5

ICD-10 Finland

Fracture of pubis

2.6

41.7

261

707

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

4.6

41.7

111

170

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.5

41.6

340

5005

L03AX13

ATC

glatiramer acetate; parenteral

5.9

41.6

101

NF3AA

NOMESCO Finland

Femur X-ray examination

1.9

41.5

562

2096

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

41.5

556

2067

G40.89

ICD-10 Finland

Other epilepsy

4.0

41.4

130

228

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

172.6

41.4

F06.33

ICD-10 Finland

Organic mood syndrome

172.6

41.4

F91.9

ICD-10 Finland

Conduct disorder, unspecified

24.3

41.3

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.6

41.2

266

732

C08CA01

ATC

amlodipine; oral

1.2

40.8

10696

67154

F06.31

ICD-10 Finland

Organic bipolar syndrome

54.4

40.6

C07AA05

ATC

propranolol; systemic

1.3

40.6

3664

20518

A10BH01

ATC

sitagliptin; oral

1.4

40.4

2392

12602

P74

ICPC

Anxiety disorder/anxiety state

1.9

40.4

569

2151

NG1AA, ,

SPAT

0.5

40.4

417

5675

R01AD58

ATC

fluticasone, combinations; nasal

0.7

40.3

2531

23156

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

40.2

815

3432

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

40.1

3019

16488

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

40.1

1008

4487

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

40.1

637

2502

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

3.0

39.9

196

465

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

6.9

39.9

N06AG02

ATC

moclobemide; oral

1.6

39.9

912

3964

R4150

NOMESCO Finland

Neuropsychological rehabilitation

3.6

39.9

143

277

R31

ICD-10 Finland

Unspecified haematuria

1.3

39.9

2854

15475

IBB01

NOMESCO Finland

Psychiatric functioning capacity evaluation

6.4

39.7

ZYY02

NOMESCO Finland

Contact between professionals and family members

11.9

39.7

Z11

ICPC

Compliance/being ill problem

3.1

39.6

179

404

N05CD08

ATC

midazolam; nasal, systemic

1.9

39.6

568

2160

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

2.2

39.6

359

1154

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.3

39.5

2650

14233

F23.91

ICD-10 Finland

Acute and transient psychosis, unspecified without acute stress factor

7.6

39.4

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

39.2

943

4151

B18.2

ICD-10 Finland

Chronic viral hepatitis C

3.2

39.2

168

367

F0232, G20,

ICD-10 Finland

315.8

39.1

XQ855, ,

SPAT

2.3

39.1

306

923

U28

ICPC

Limited function/disability (U)

2.4

39.1

296

880

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

4.7

39.0

101

151

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.6

39.0

917

4015

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

+∞

38.9

N07AA05, ,

ATC

+∞

38.9

EB1VA, ,

NOMESCO Finland

0.7

38.9

2130

19896

U13

ICPC

Bladder symptom/complaint other

1.8

38.7

688

2793

F002, G308,

ICD-10 Finland

162.0

38.7

SPAT1265

SPAT

Breathalyser

3.1

38.7

174

392

WX892

NOMESCO Finland

Monitored bed care

1.4

38.6

1850

9406

F0230, G20,

ICD-10 Finland

308.8

38.2

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

2.4

38.0

293

878

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.7

38.0

223

585

LAITO, ,

NOMESCO Finland

11.8

37.9

E000001, ,

ATC

1.3

37.9

3932

22393

F10.59

ICD-10 Finland

Alcohol psychosis, mixed type

9.9

37.8

ZXD35

NOMESCO Finland

Usual procedure

1.7

37.8

713

2945

AA1AA

NOMESCO Finland

Head X-ray examination

2.8

37.8

212

543

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

3.2

37.7

163

358

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

4.7

37.7

150

F30.9

ICD-10 Finland

Manic episode, unspecified

5.3

37.5

115

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.1

37.4

373

1246

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

301.7

37.3

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.2

37.2

109

181

-2, ,

ICPC

3.3

37.2

152

322

R4130

NOMESCO Finland

Speech therapy

1.8

37.2

597

2352

U07

ICPC

Urine symptom/complaint other

1.4

37.1

2101

10984

R01AD59

ATC

mometasone, combinations; nasal

0.5

37.0

274

4180

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

36.9

440

1571

RT250, ,

NOMESCO Finland

7.2

36.9

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

2.6

36.9

235

643

T08

ICPC

Weight loss

2.0

36.9

410

1428

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

3.8

36.9

126

236

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

36.8

7102

43231

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.0

36.8

434

1544

A03FA01

ATC

metoclopramide; systemic, rectal

0.8

36.7

3569

30873

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.6

36.7

934

4170

N06AB05

ATC

paroxetine; oral

1.6

36.6

995

4510

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

36.5

586

2309

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.4

36.5

247

3895

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

36.5

699

2900

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

36.4

1827

9360

F06.6

ICD-10 Finland

Organic emotionally labile [asthenic] disorder

294.6

36.4

F02.80

ICD-10 Finland

Dementia in another specified disease that is classified elsewhere without additional symptoms

66.2

36.4

WPA10, ,

SPAT

4.1

36.3

110

188

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

2.4

36.2

264

771

Z72.2

ICD-10 Finland

Drug use

4.7

36.2

141

N07

ICPC

Convulsion/seizure

5.3

36.2

111

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.3

36.1

291

890

IEV99

NOMESCO Finland

Other psychiatric network intervention

5.5

36.0

101

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.1

36.0

375

1274

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.6

36.0

833

3632

F32.8

ICD-10 Finland

Other depressive episodes

2.5

36.0

251

718

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

36.0

3642

31367

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

3.1

35.9

162

366

T90

ICPC

Diabetes non-insulin dependent

1.2

35.8

6324

38148

GD1QA, ,

SPAT

4.8

35.8

134

IEY01

NOMESCO Finland

Psychoeducation, individual

4.3

35.7

104

172

A05

ICPC

Feeling ill

1.6

35.6

949

4282

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.6

35.6

132

262

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

35.6

2383

12784

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

35.6

6987

42577

D07AA02

ATC

hydrocortisone; topical

1.3

35.5

2573

13964

Angiography of the heart and coronary arteries

1.4

35.5

1749

8933

Y94.1

ICD-10 Finland

Accident in connection with service housing

9.5

35.4

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.5

35.4

315

4504

A02BC01

ATC

omeprazole; systemic

1.2

35.4

6541

39621

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

12.1

35.1

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

35.1

10616

67191

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

35.1

320

1032

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

5.6

34.9

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

6.2

34.8

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

4.1

34.8

105

179

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

4.1

34.8

105

179

NB6AA

NOMESCO Finland

Humerus X-ray examination

1.8

34.7

530

2056

S42.0

ICD-10 Finland

Fracture of clavicle

1.8

34.7

565

2236

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

34.5

1374

6749

205

Kela drug reimbursment

Chronic hypertension

1.2

34.4

7761

47874

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.6

34.2

684

7758

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.6

34.2

847

3757

F28

ICD-10 Finland

Other nonorganic psychotic disorders

6.1

34.0

A41.9

ICD-10 Finland

Sepsis, unspecified

1.6

33.9

918

4157

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

273.4

33.7

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

3.5

33.7

129

262

F23.8

ICD-10 Finland

Other acute and transient psychotic disorders

6.2

33.7

G93.4

ICD-10 Finland

Encephalopathy, unspecified

4.6

33.6

136

Z3231

NOMESCO Finland

Registered nurse

1.2

33.6

6330

38385

P71

ICPC

Organic psychosis other

14.1

33.5

S01

ICD-10 Finland

Open wound of head

2.3

33.3

278

864

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

33.3

266

811

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

5.9

33.2

TPH04

NOMESCO Finland

Cathetrisation of vein

1.2

33.2

5276

31458

S01.3

ICD-10 Finland

Open wound of ear

2.3

33.1

283

888

N04BX04

ATC

opicapone; oral

4.6

32.8

133

N06AX22

ATC

agomelatine; oral

2.2

32.8

297

955

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.2

32.8

7260

44665

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

7.6

32.7

OAB41, ,

SPAT

2.4

32.7

246

730

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

32.7

1930

10153

164

Kela drug reimbursment

Fingolimod

7.8

32.6

A10AC01

ATC

insulin (human); parenteral

1.4

32.6

1676

8620

G21.1

ICD-10 Finland

Other drug-induced secondary parkinsonism

4.2

32.2

159

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

32.2

1070

10896

F30.0

ICD-10 Finland

Hypomania

5.5

32.1

RT150, ,

NOMESCO Finland

7.6

32.1

L03AA13

ATC

pegfilgrastim; parenteral

0.5

32.1

330

4497

A04AA01

ATC

ondansetron; systemic, rectal

0.7

32.0

973

10084

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.4

32.0

234

685

R4120

NOMESCO Finland

Occupational therapy

1.4

32.0

1332

6598

IGY02, ,

SPAT

2.5

32.0

220

626

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

8.7

32.0

F0012, G301,

ICD-10 Finland

259.2

32.0

F02.09

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

259.2

32.0

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.9

31.9

421

1558

IAB12

NOMESCO Finland

Psychiatric psychosis consultation

11.1

31.9

SPAT1211

SPAT

Application of soft bandage

1.4

31.9

1930

10189

F23.3

ICD-10 Finland

Other acute predominantly delusional psychotic disorders

4.0

31.8

100

176

XQ858, ,

SPAT

2.8

31.8

176

448

S02.20

ICD-10 Finland

Fracture of nasal bones, closed

2.1

31.7

328

1112

R47.0

ICD-10 Finland

Dysphasia and aphasia

2.3

31.7

269

842

ZX120, ,

SPAT

2.1

31.6

340

1170

T74.1

ICD-10 Finland

Physical abuse

2.5

31.6

219

625

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.6

31.6

116

229

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.5

31.6

1123

5395

R74

ICPC

Upper respiratory infection acute

0.8

31.6

3583

30523

F01.22

ICD-10 Finland

Subcortical vascular dementia with additional symptoms, mainly hallucinations

91.5

31.4

Z3226

NOMESCO Finland

Physiotherapist

1.2

31.4

3952

22973

B01AF02

ATC

apixaban; oral

1.2

31.3

3825

22156

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

4.6

31.3

127

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

4.1

31.2

160

SPAT1312

SPAT

General health counselling

1.2

31.2

6748

41387

D17

ICPC

Incontinence of bowel

2.2

31.1

279

894

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

252.2

31.1

AA1ED

NOMESCO Finland

Trauma CT of head and neck

2.9

31.0

163

403

G04CA01

ATC

alfuzosin; oral

1.3

31.0

3255

18526

SDA03

NOMESCO Finland

Periodontal treatment

0.8

31.0

6186

49846

Z27

ICPC

Fear of a social problem

3.9

30.9

177

XCK00

NOMESCO Finland

Perimetry

1.4

30.8

1460

7402

F02.89*E03.9

ICD-10 Finland

Dementia in hypothyroidism, acquired

+∞

30.8

2930A

ICD-9 Finland

Transient organic psychotic conditions, Acute delirium

+∞

30.8

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

30.7

307

4223

N05AX13

ATC

paliperidone; systemic

4.3

30.7

147

G40.10

ICD-10 Finland

Simple partial seizures

2.7

30.7

173

445

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

5.8

30.6

F25.01

ICD-10 Finland

Schizoaffective syndrome, manic type with prolonged schizophrenic than bipolar symptoms

4.9

30.6

107

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.1

30.3

140

321

SPAT1227

SPAT

Substance abuse rehabilitation

3.4

30.3

119

246

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.7

30.3

172

444

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

3.1

30.2

139

318

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

4.1

30.2

155

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

4.4

30.2

134

F21

ICD-10 Finland

Schizotypal disorder

3.8

30.2

103

193

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

245.1

30.2

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

4.8

30.2

114

SPAT1313

SPAT

Guidance and counselling related to accident prevention

3.1

30.1

138

315

U29

ICPC

Urinary symptom/complaint other

1.6

30.1

737

3259

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.5

30.0

351

4598

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.2

30.0

3696

21420

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14470

74753

1.76

307.65

2.5

2.4

77.15

80.14

nmol/l

26.96

12702

65793

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1562

531

21.87

307.65

1.0

659.05

846.11

ng/l

13.23

1134

330

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1893

2769

5.09

307.65

1.3

1.4

707.42

2372.49

e6/l

1.30

1486

2197

(3024561) Albumin [Mass/volume] in Serum or Plasma

16143

83082

1.89

307.65

4.8

5.2

34.64

34.82

g/l

3.33

14831

77552

(3031040) Bacteria [#/volume] in Urine by Automated count

19850

112874

1.85

307.65

6.8

5.2

2759.62

1353.16

e6/l

2.41

421

1591

(3023368) Bacteria identified in Blood by Culture

11462

54855

1.80

307.65

4.9

4.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1885

2732

5.13

307.65

1.3

1.4

19.50

35.85

e6/l

0.98

1387

2032

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

5638

22863

1.92

307.65

2.1

1.9

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1549

535

21.51

307.65

1.0

363.96

257.98

ng/l

7.18

1155

349

(3023410) Appearance of Cerebral spinal fluid

825

1201

4.95

307.65

1.3

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2095

3212

4.88

307.65

1.2

1.3

527.24

579.30

mg/l

1.76

1971

3090

(3019309) Folate [Moles/volume] in Red Blood Cells

10240

32086

2.98

307.65

1.9

1.8

1172.99

1138.93

nmol/l

2.87

7803

23655

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17156

81417

2.28

307.65

2.7

2.2

93.28

94.91

pmol/l

4.14

9696

42496

(3021960) Folate [Moles/volume] in Serum or Plasma

13970

53573

2.69

307.65

2.0

1.7

20.05

20.26

nmol/l

0.71

12080

44328

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7971

32801

2.00

307.65

2.1

2.0

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

18346

94075

2.11

307.65

7.6

1.22

1.21

mmol/l

18.05

15754

80642

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1909

2804

5.07

307.65

1.2

1.3

3.91

3.79

mmol/l

3.56

1807

2659

(3015377) Calcium [Moles/volume] in Serum or Plasma

12882

61720

1.88

307.65

3.0

3.7

2.35

mmol/l

1.26

11603

55199

(3018418) pH of Serum or Plasma

11785

56475

1.82

307.65

4.0

4.6

7.40

5.29

8826

40587

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6070

24634

1.94

307.65

2.1

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1335

1597

6.13

307.65

5.2

4.9

351.51

350.64

umol/l

0.06

1171

1377

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

8807

36848

2.00

307.65

2.8

3.3

2.46

2.47

mmol/l

5.70

7955

32794

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8990

37135

2.04

307.65

1.9

1.8

10588520.28

32925344.35

pmol/l

5.56

7329

29789

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

11833

57595

1.78

307.65

2.8

2.2

278.83

208.47

u/l

9.66

11220

53995

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1562

536

21.66

307.65

1.0

46.51

29.71

ng/l

28.52

1146

340

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16516

84646

1.93

307.65

6.9

1.21

mmol/l

6.14

15137

77790

(3023183) Ammonium ion [Moles/volume] in Plasma

1539

3769

2.98

297.73

2.3

2.4

28.55

33.91

umol/l

14.62

1326

3366

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9923

49583

1.64

290.82

2.5

2.4

2.89

2.96

mg/l

1.71

8467

42509

(3013826) Glucose [Moles/volume] in Serum or Plasma

18026

104882

1.60

271.88

6.4

5.3

7.00

6.83

mmol/l

16.93

17379

100150

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13043

70775

1.56

261.45

5.2

4.3

77.05

77.77

ng/l

0.01

10850

55296

(3032080) INR in Blood by Coagulation assay

15723

90380

1.52

229.11

19.9

18.3

1.35

1.33

inr

7.00

13687

75783

(3037467) Urinalysis macro (dipstick) panel - Urine

19108

115652

1.53

206.63

6.0

5.0

2.57

70.68

0.49

194

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3133

12457

1.87

196.60

1.9

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

19461

119181

1.51

187.52

4.6

4.5

15.17

15.07

pmol/l

5.80

17485

107198

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3266

13493

1.80

180.19

2.2

1.7

1.68

1.56

12.82

2763

11326

(3035350) Ketones [Presence] in Urine by Test strip

15328

89951

1.45

179.25

5.2

4.3

4.06

3.92

estimate

0.03

3415

19722

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

702

1465

3.43

174.51

1.3

1.5

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

400

540

5.27

171.31

1.2

1.3

55.67

62.57

0.41

(3009261) Glucose [Presence] in Urine by Test strip

15358

90686

1.43

168.83

5.2

4.3

0.43

0.42

estimate

0.01

3168

18485

(3015736) pH of Urine

12558

71569

1.43

167.18

4.5

3.8

6.34

6.26

10.45

6704

37933

(3021601) Nitrite [Presence] in Urine by Test strip

15069

88877

1.42

164.85

5.1

4.2

0.00

estimate

3.27

3277

19118

(3019150) Specific gravity of Urine by Refractometry

7445

38483

1.49

164.49

5.5

4.6

1.02

1.13

kg/l

1.04

5252

26063

(3028707) Methadone [Presence] in Urine by Screen method

521

947

3.92

157.29

4.2

2.7

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

342

457

5.31

148.04

21.0

18.8

1279.58

1431.92

nmol/l

2.40

331

441

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1928

7152

1.96

146.75

2.2

762.68

566.32

ug/l

0.87

1830

6828

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4372

20643

1.58

143.26

3.8

3.9

5.82

5.81

kpa

0.26

4264

20164

(3002582) Erythrocytes [#/volume] in Urine

10940

62084

1.40

140.35

4.2

3.6

89.74

96.27

e6/l

0.17

8625

47839

(3012544) pH of Venous blood

4401

20920

1.57

139.73

3.8

3.9

7.38

1.53

2615

12210

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20704

130972

1.45

139.59

8.1

9.0

81.13

82.00

u/l

1.23

19469

123996

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10135

56938

1.40

136.92

2.8

2.7

127.79

64.66

u/l

0.52

9351

52372

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

320

434

5.23

136.41

15.5

14.0

728.94

3878.21

nmol/l

0.52

308

411

(3002032) Base excess in Venous blood by calculation

4239

20088

1.57

136.01

3.9

1.93

1.76

mmol/l

1.88

3754

17592

(3024354) Oxygen [Partial pressure] in Venous blood

3720

17112

1.61

135.19

3.4

3.2

4.37

4.48

kpa

2.16

3614

16661

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

22294

143546

1.48

131.31

6.1

5.6

2.00

2.03

mu/l

1.52

20379

130141

(4198724) Urine methamphetamine measurement

246

278

6.27

125.27

3.1

2.4

—

(3026782) Osmolality of Urine

6980

37320

1.42

121.83

3.5

3.1

525.70

531.17

mosm/kgh2o

1.30

6182

32684

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

11256

65218

1.36

121.02

5.4

4.3

0.64

0.77

estimate

0.15

2697

15529

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2818

12454

1.66

118.95

7.3

7.0

24.52

24.56

mmol/l

0.20

2732

11934

(3024666) Lithium [Moles/volume] in Serum or Plasma

312

469

4.72

118.94

15.1

13.3

0.66

0.63

mmol/l

1.23

284

427

(3018095) Leukocytes [#/volume] in Urine

11681

68323

1.35

116.64

5.0

4.3

134.51

115.62

e6/l

1.02

8731

49240

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

505

9511

0.36

116.07

1.8

2.1

3.24

3.44

ratio

3.70

417

7598

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

15515

95007

1.34

112.08

5.8

7.1

11.82

12.23

umol/l

3.39

14658

90678

(1761868) Lipid panel - Serum or Plasma

5322

49568

0.70

111.94

3.8

3.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

545

1285

3.02

111.47

1.1

64.00

60.94

au/ml

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6907

37442

1.40

109.06

4.8

4.3

210.74

486.77

ng/l

12.59

6086

31941

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3107

14416

1.58

106.95

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1573

6051

1.88

106.50

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

9464

54128

1.35

106.37

4.1

3.5

0.52

0.45

e6/l

1.62

7265

40311

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

267

389

4.86

105.45

1.2

1.3

35.76

20.86

0.93

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

19218

122030

1.36

105.09

4.7

14.85

14.11

mm/h

7.65

17616

112873

(3000850) Epithelial cells [#/volume] in Urine

7824

43510

1.37

104.95

3.2

2.8

5.67

4.94

e6/l

5.37

7214

39521

(3029937) Albumin [Presence] in Urine by Test strip

9007

51241

1.35

104.26

5.4

4.4

0.00

estimate

0.03

2870

17341

(36304419) Bacteria [Presence] in Urine

8903

50612

1.35

103.30

4.1

3.5

9.81

200.14

estimate

0.98

267

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

403

824

3.47

103.22

2.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

363

691

3.73

102.98

1.1

—

(21494755) Public health laboratory ask at order entry panel

264

6438

0.28

101.04

1.2

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

487

1139

3.04

100.98

1.2

1.3

2.15

2.27

mmol/l

0.94

451

1051

(3020191) Ethanol [Moles/volume] in Serum or Plasma

468

1079

3.08

99.38

1.9

1.3

1.09

1.17

promille

0.45

374

849

(3019977) pH of Arterial blood

4743

24396

1.44

99.13

7.6

7.4

7.42

0.03

2908

13111

(3003396) Base excess in Arterial blood by calculation

4714

24241

1.44

98.58

7.5

7.3

1.29

0.92

mmol/l

7.59

3845

20175

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

250

365

4.85

98.53

2.6

142.49

140.44

nmol/l

0.09

220

321

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4738

24425

1.44

97.66

7.5

7.4

5.06

5.09

kpa

1.16

4569

23471

(3027801) Oxygen [Partial pressure] in Arterial blood

4735

24410

1.44

97.58

7.5

7.4

11.67

12.10

kpa

7.10

4561

23451

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

310

6792

0.31

96.86

1.7

1.8

3.15

3.39

mmol/l

2.74

225

4837

(3027945) Reticulocytes/Erythrocytes in Blood

4856

25203

1.43

96.32

2.2

2.5

1.80

1.78

0.51

4162

22378

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

480

1155

2.96

94.84

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1396

5366

1.87

94.49

1.9

1.6

0.31

0.30

mg/l

0.25

664

2446

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

8024

68539

0.75

92.13

1.9

2.0

1.31

mmol/l

0.12

6642

55604

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5608

30058

1.39

91.97

2.0

29.51

29.89

4.73

5437

29273

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3157

15218

1.52

90.55

4.0

4.2

1.23

mmol/l

2.29

2651

13093

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

376

803

3.32

90.23

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2710

12644

1.56

90.08

3.5

3.3

127.39

127.54

g/l

0.13

2644

12266

(1001926) Buprenorphine [Presence] in Urine by Screen method

594

1653

2.56

89.53

4.1

2.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

2084

9181

1.64

87.73

5.6

4.9

1.66

1.57

2.40

2006

8732

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3945

20014

1.45

87.51

8.3

8.2

119.89

120.08

g/l

0.23

3873

19573

(3011288) Drugs identified in Urine by Screen method Nominal

530

1411

2.67

87.14

6.2

3.0

—

(3016502) Oxygen saturation in Arterial blood

4234

21814

1.43

86.33

7.8

7.7

95.31

95.34

0.09

4091

21089

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3474

17317

1.47

84.12

2.7

2.4

5.68

7.15

ug/l

5.48

2793

15214

(40768804) Tissue Pathology biopsy report

8196

69213

0.76

83.86

2.2

2.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1920

8395

1.65

83.06

5.7

5.2

0.88

0.86

1.20

1848

7948

(3012095) Magnesium [Moles/volume] in Serum or Plasma

5913

32569

1.35

80.06

3.0

3.3

0.81

mmol/l

3.38

5436

30483

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

23330

154805

1.39

77.27

25.4

19.2

28.81

27.14

mg/l

11.03

20788

130675

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

10830

65116

1.28

76.62

3.3

3.4

1856.67

1650.42

ng/l

3.81

9420

57122

(3047181) Lactate [Moles/volume] in Blood

1382

5672

1.75

75.19

6.2

6.0

1.41

1.33

mmol/l

1.74

1249

5034

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2297

10751

1.55

74.56

3.0

2.9

1.23

1.19

1.28

2290

10698

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2228

10374

1.55

73.98

4.5

4.2

45.92

46.76

0.85

2205

10232

(3027273) Bicarbonate [Moles/volume] in Venous blood

2050

9374

1.58

73.62

3.7

3.6

25.27

25.19

mmol/l

0.49

1988

9101

(3014111) Lactate [Moles/volume] in Serum or Plasma

3606

18580

1.42

72.24

7.0

7.3

1.44

1.35

mmol/l

4.33

3527

18177

(3016879) Cocaine [Presence] in Urine

628

1985

2.25

71.76

4.1

2.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2265

10657

1.54

71.67

3.0

2.8

0.64

0.62

2.98

2260

10616

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

181

270

4.74

69.77

1.9

2.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1607

7020

1.65

69.40

2.0

1.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

11992

73612

1.26

68.69

3.2

143.42

156.36

ug/l

5.44

10752

67379

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

181

274

4.67

68.62

1.9

2.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3044

15342

1.44

68.52

2.0

2.4

394.29

385.50

nmol/l

1.30

2754

14219

(3003181) Sodium [Moles/volume] in Urine

1020

3933

1.85

68.06

1.4

61.34

60.69

mmol/l

0.19

821

3161

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4859

26579

1.35

67.11

5.2

5.9

1.02

1.04

mmol/l

4.77

4467

24639

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

215

383

3.97

66.83

1.2

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2411

11695

1.49

65.84

3.8

4.0

24.31

24.16

mmol/l

1.37

2368

11552

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3291

16960

1.41

65.32

3.2

3.1

218.18

240.15

ng/l

1.63

3047

15643

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

291

653

3.16

64.71

2.3

1.7

103.55

105.60

umol/l

0.04

144

345

(3014271) Vancomycin [Susceptibility]

384

1010

2.70

64.69

3.2

2.9

—

(3022948) Iron [Moles/volume] in Serum or Plasma

6073

34461

1.31

64.55

2.5

2.8

11.22

12.26

umol/l

24.04

5460

31998

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5567

31241

1.32

64.06

3.8

3.4

2.91

2.38

e6/l

2.34

2797

15739

(3023520) Reticulocytes [#/volume] in Blood

3774

19971

1.38

64.00

2.2

2.6

67.71

68.42

e9/l

0.54

2825

14781

(3041096) Erythrocytes [Presence] in Urine by Automated

7666

44918

1.28

63.39

4.7

3.8

0.38

0.37

estimate

0.02

2555

14983

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1679

7596

1.59

62.76

2.1

2.0

—

(3000764) Benzodiazepines [Presence] in Urine

631

2128

2.11

61.51

4.2

2.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

270

597

3.20

61.50

2.6

2.3

57.28

52.06

umol/l

1.54

224

507

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5997

34179

1.30

61.13

3.7

3.2

1.37

1.21

e6/l

0.91

3264

18715

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2977

15243

1.42

60.98

3.3

4.0

88.86

96.50

ng/l

5.08

2447

12964

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

316

773

2.90

60.80

1.3

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

7297

42684

1.27

60.56

4.8

4.1

0.34

0.25

0.31

476

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

242

504

3.40

60.48

3.2

2.8

29.06

28.57

umol/l

0.24

168

386

(3027008) Opiates [Presence] in Urine

629

2137

2.09

60.16

4.2

2.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5728

32514

1.30

60.01

2.5

2.7

2.23

2.27

g/l

7.59

5109

29965

(3028300) Cannabinoids [Presence] in Urine

630

2145

2.09

59.92

4.2

2.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

1459

6520

1.61

57.28

4.3

4.2

1.42

1.39

mmol/l

0.33

1432

6393

(3019225) pH of Specimen

3541

18874

1.37

56.82

4.4

7.37

7.36

0.79

2511

13399

(3027944) Amphetamines [Presence] in Urine

603

2094

2.05

54.46

4.2

2.0

—

(3039000) Anion gap in Blood by calculation

972

3969

1.75

53.61

7.1

6.9

11.48

11.25

mmol/l

1.08

900

3577

(3018572) Chloride [Moles/volume] in Blood

972

3970

1.75

53.57

7.1

6.9

104.66

104.85

mmol/l

0.52

900

3579

(3007853) Bacteria identified in Skin by Aerobe culture

3887

21193

1.34

53.50

2.0

1.9

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3448

18488

1.36

52.95

2.1

2.2

0.20

g/l

3.20

3097

17186

(3008295) Osmolality of Serum or Plasma

589

2054

2.04

52.60

1.4

1.3

277.36

276.27

mosm/kgh2o

0.42

433

1551

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15231

97667

1.22

50.81

4.1

3.4

54.43

55.96

u/l

1.02

13927

89827

(3020891) Body temperature

1939

9501

1.47

49.77

5.1

4.6

36.92

36.90

°c

1.84

1916

9416

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1701

17165

0.68

49.72

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

1215

5382

1.61

49.34

4.7

4.5

3.89

3.90

mmol/l

0.41

1206

5335

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

2276

11539

1.42

48.67

3.4

3.7

2.10

1.90

mmol/l

1.58

1634

8634

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

620

7856

0.54

47.50

1.2

1.3

—

(3000991) Gas panel - Venous blood

3312

17942

1.34

47.09

8.2

8.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

23863

161090

1.31

46.90

31.4

23.5

139.51

139.58

mmol/l

2.71

23449

157919

(3006270) Folate [Moles/volume] in Blood

406

1280

2.25

46.78

1.3

1.2

321.41

329.15

nmol/l

0.28

327

1003

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1805

8851

1.46

46.04

2.0

1.9

2.24

2.15

ug/l

0.11

1495

7882

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5263

30412

1.27

46.03

2.6

2.8

20.47

21.70

8.66

4706

28204

(3023103) Potassium [Moles/volume] in Serum or Plasma

23869

161295

1.30

44.89

31.5

23.7

3.99

4.00

mmol/l

2.68

23434

157903

(3014051) Protein [Presence] in Urine by Test strip

7550

45564

1.23

44.45

3.7

3.2

0.10

0.07

0.68

283

1365

(3040151) Glucose [Moles/volume] in Capillary blood

593

2204

1.91

44.26

17.2

6.6

7.94

7.32

mmol/l

1.45

486

1830

(4024509) Urine culture

1751

8620

1.46

43.71

2.2

2.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2582

13614

1.37

43.56

3.6

3.9

5.19

5.14

kpa

1.94

2382

13004

(3009343) pH of Capillary blood

2513

13232

1.37

42.72

3.6

3.9

7.42

0.33

2129

11079

(4027681) Cerebrospinal fluid IgG ratio and IgG index

237

603

2.78

42.65

1.2

0.56

0.55

ratio

0.08

138

349

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

110

164

4.73

42.60

2.2

1.9

19.79

17.06

umol/l

1.26

110

164

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

410

1356

2.14

42.10

1.4

1.8

1704.00

2367.69

titre

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

305

888

2.43

42.06

1.2

1.1

40.88

47.50

mg/l

1.75

253

757

(4035726) Immunohistochemistry procedure

1793

17418

0.70

41.95

1.3

1.4

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

2306

0.24

40.83

1.2

0.60

0.61

ratio

0.17

422

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

291

847

2.43

40.18

1.1

287.30

318.40

mg/l

0.95

252

750

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

175

391

3.16

39.40

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

172

384

3.16

38.78

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2997

26637

0.77

38.47

1.3

14.02

13.89

u/ml

0.03

959

9311

(3020779) Urea [Moles/volume] in Serum or Plasma

3408

19186

1.28

35.84

6.1

6.9

10.56

11.10

mmol/l

3.77

3196

18235

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2240

11917

1.35

35.34

9.5

15.83

15.89

0.47

2178

11532

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2909

16075

1.30

35.23

2.8

2.6

0.56

0.46

e6/l

1.22

2819

15504

(3028271) Lactate [Moles/volume] in Capillary blood

721

3057

1.68

34.73

2.3

1.9

1.81

1.70

mmol/l

1.68

707

2976

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

267

801

2.36

34.60

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3440

19499

1.27

34.12

4.8

3.7

—

(3024928) Oxygen saturation in Venous blood

1070

5016

1.52

33.87

2.9

3.0

58.98

60.63

1.49

1011

4839

(3002256) Pathology report gross observation

2817

24856

0.77

33.69

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1063

4985

1.52

33.59

2.5

2.3

127.03

127.79

g/l

0.45

870

3753

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

880

3987

1.57

32.47

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

880

3987

1.57

32.47

1.4

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1229

5999

1.46

31.90

1.4

1.6

—

(3045716) Anion gap in Serum or Plasma by calculation

524

2092

1.78

31.30

3.4

2.9

10.84

10.54

mmol/l

0.93

515

2072

(3042517) Benzodiazepines panel - Urine

7.18

31.23

2.4

2.6

—

(1616796) Gas panel - Central venous blood

977

4578

1.52

30.99

3.8

3.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3312

28376

0.80

30.62

1.3

41.62

39.78

iu/ml

0.24

997

8562

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

127

273

3.28

30.51

2.8

2.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3763

21835

1.25

30.25

10.2

7.7

—

(3016038) Potassium [Moles/volume] in Urine

381

1390

1.94

30.18

1.2

31.64

34.95

mmol/l

2.04

324

1191

(40767503) Oxygen content in Capillary blood by calculation

915

4281

1.52

29.24

3.0

2.7

16.02

16.11

0.34

895

4201

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8568

53913

1.17

28.68

3.5

3.3

35.42

35.58

u/l

0.05

8007

50390

(3020630) Protein [Mass/volume] in Serum or Plasma

3250

18709

1.25

27.86

2.4

2.7

65.71

66.04

g/l

1.54

2847

17055

(3010421) pH of Blood

1242

6245

1.42

27.46

4.0

3.8

7.41

0.51

1212

6166

(3008037) Lactate [Moles/volume] in Venous blood

1060

5178

1.46

27.40

4.0

3.4

1.66

1.60

mmol/l

1.19

1039

5055

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

192

3.60

27.06

1.2

1.3

29.82

53.46

3.67

(3028626) Oxygen [Partial pressure] in Capillary blood

1045

5110

1.46

26.87

3.0

3.2

7.78

7.94

kpa

2.49

1016

5001

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

213

650

2.31

26.70

1.9

2.1

57.99

57.19

ug/l

0.07

207

635

(3019198) Lymphocytes [#/volume] in Blood

13640

89155

1.15

26.63

6.5

6.4

1.77

1.88

e9/l

6.31

11789

76954

(3001604) Monocytes [#/volume] in Blood

13404

87532

1.15

26.42

6.4

6.3

0.63

0.62

e9/l

2.48

11392

73625

(3021901) Oxygen saturation in Capillary blood

934

4485

1.48

26.35

3.0

3.1

88.66

89.34

2.09

906

4373

(3006315) Basophils [#/volume] in Blood

13447

87889

1.15

25.99

6.4

0.04

e9/l

3.81

11433

73969

(3001019) Free T4 and TSH panel - Serum or Plasma

272

3675

0.52

25.77

1.6

1.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

196

3.49

25.64

3.8

3.3

41.64

39.98

umol/l

0.27

153

(3019069) Monocytes/Leukocytes in Blood

12487

81294

1.15

25.23

6.7

9.07

9.13

1.25

11595

75663

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2363

13265

1.28

24.90

7.6

24.93

24.77

mmol/l

1.14

2334

13170

(3013115) Eosinophils [#/volume] in Blood

13734

90073

1.14

24.68

6.7

6.6

0.19

0.20

e9/l

2.87

11782

77108

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1934

10593

1.31

24.64

1.6

1.7

1.60

1.58

g/l

0.51

1581

9113

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1412

7387

1.36

24.63

2.9

3.1

24.92

24.78

mmol/l

0.58

1379

7272

(3006504) Eosinophils/Leukocytes in Blood

12437

81071

1.14

24.30

6.6

2.72

2.84

6.76

11551

75463

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1760

15859

0.77

24.20

1.5

1.6

—

6.02

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2110

18578

0.78

24.15

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2378

13423

1.27

23.92

9.7

9.3

0.66

0.62

4.09

2363

13349

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2444

13856

1.26

23.69

9.5

9.1

1.40

1.29

5.75

2429

13771

(3022096) Basophils/Leukocytes in Blood

12430

81120

1.14

23.58

6.7

0.62

0.66

15.83

11545

75536

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

204

648

2.22

23.37

1.1

301.64

613.05

ng/l

0.57

198

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1009

5033

1.43

23.34

3.7

3.2

0.78

0.81

nmol/l

2.16

804

4051

(3012501) Base excess in Blood by calculation

850

4113

1.47

23.10

4.4

4.2

2.53

2.68

mmol/l

0.80

593

2822

(3013290) Carbon dioxide [Partial pressure] in Blood

850

4115

1.47

23.05

4.4

4.2

5.01

4.99

kpa

0.34

820

4025

(3003694) ABO and Rh group [Type] in Blood

5572

44391

0.85

22.81

1.3

—

(3018010) Neutrophils/Leukocytes in Blood

12357

80718

1.14

22.81

6.5

59.91

58.39

35.55

11674

76673

(3022621) pH of Urine by Test strip

2395

13626

1.26

22.49

3.6

2.9

6.13

6.03

5.98

1784

9493

(3027315) Oxygen [Partial pressure] in Blood

851

4144

1.46

22.40

4.4

4.3

8.32

8.47

kpa

1.57

820

4054

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

121

4.02

22.19

1.1

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

14801

97932

1.14

22.05

9.4

10.0

4.56

4.27

e9/l

31.41

12812

83885

(3038515) Glucose [Moles/volume] in Venous blood

888

4379

1.44

21.88

4.2

3.6

7.91

7.61

mmol/l

1.72

869

4278

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

329

1276

1.82

21.78

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

334

1302

1.81

21.75

1.3

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

123

323

2.68

21.15

1.4

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

435

2.42

20.72

1.1

—

(40758558) Short blood count panel - Blood

8153

52045

1.14

20.67

6.7

6.9

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

286

3559

0.56

20.58

1.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

20787

151043

0.87

20.47

5.2

5.5

1.43

1.45

mmol/l

4.70

18598

137373

(3002030) Lymphocytes/Leukocytes in Blood

12552

82449

1.13

20.21

6.7

24.71

26.22

41.55

11791

77620

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

215

3.05

20.06

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

23912

163965

1.19

19.91

32.8

26.1

83.99

83.07

umol/l

2.80

23562

161803

(3042936) Bacteria identified in Isolate by Culture

4446

27193

1.18

19.85

2.2

2.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

119

3.85

19.81

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

3.43

19.74

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2410

13926

1.24

19.61

9.7

9.2

93.44

93.82

2.11

2398

13889

(3035285) Chloride [Moles/volume] in Venous blood

539

2455

1.55

19.58

2.6

2.5

105.99

105.48

mmol/l

1.47

534

2433

(3041354) Potassium [Moles/volume] in Venous blood

539

2455

1.55

19.58

2.6

2.5

4.08

4.09

mmol/l

0.25

534

2434

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

4.29

19.57

1.3

47.36

41.56

0.36

(3033705) Calcium.ionized [Moles/volume] in Venous blood

529

2429

1.54

18.56

2.7

2.5

1.20

mmol/l

0.29

524

2408

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

800

7786

0.71

18.48

2.9

4.2

85.82

79.91

u/ml

0.11

769

7498

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

242

2.82

18.40

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

438

4741

0.64

17.83

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

289

1148

1.78

17.79

2.2

2.0

8.54

8.04

mmol/l

0.98

289

1148

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

189

653

2.04

17.66

1.1

1.12

u/l

0.05

307

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

152

486

2.21

17.30

1.5

1.2

104.86

134.25

nmol/l

1.58

103

340

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

4.26

17.04

1.2

1.3

15.97

13.25

0.26

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1626

14152

0.80

16.59

2.3

2.2

11.86

12.65

nmol/l

2.90

1376

12431

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1305

7152

1.30

16.51

3.9

4.1

25.07

24.87

mmol/l

1.54

1140

6547

(3045414) Leukocytes [Presence] in Urine

3020

18165

1.19

16.15

2.3

2.2

0.00

0.01

estimate

0.67

484

3406

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

21039

152138

0.88

15.71

5.3

5.6

4.30

4.46

mmol/l

86.06

18936

139579

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

254

1011

1.77

15.60

1.6

1.4

14.56

13.97

umol/l

0.56

237

938

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

186

2.92

15.53

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

122

374

2.30

15.38

1.6

1.4

0.34

0.28

mmol/l

0.30

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3411

20818

1.17

15.30

2.5

2.8

8.84

9.79

umol/l

1.48

2912

18401

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

19949

144639

0.89

15.16

4.5

4.7

1.27

1.28

mmol/l

1.03

17599

129798

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

173

616

1.98

14.98

3.7

2.8

4.89

4.99

kpa

0.47

173

616

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

173

616

1.98

14.98

3.7

2.9

10.34

10.29

kpa

0.06

173

616

(3034988) Calcium [Moles/volume] in Capillary blood

102

292

2.46

14.93

1.8

1.7

1.19

1.17

mmol/l

1.90

279

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5793

36792

1.14

14.89

1.7

1.56

1.48

mg/l

0.76

4614

29047

(1002224) Polysomnography panel

500

5075

0.69

14.76

1.1

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

4.28

14.76

1.2

1.3

1.04

2.16

0.62

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1215

0.38

14.53

1.5

1.6

758.42

1004.29

mu/l

2.34

1009

(3022145) Colonoscopy Study observation

2557

21006

0.84

14.43

1.4

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

146

3.09

14.24

1.3

17.92

14.89

pmol/l

0.29

122

(40761536) Microorganisms panel - Urine sediment

2300

13651

1.20

14.20

5.5

4.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

945

5060

1.32

14.19

5.2

4.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

822

4319

1.35

14.03

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

4.18

14.01

1.0

—

(40768800) Prostate Pathology biopsy report

490

4942

0.69

13.99

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

579

2876

1.42

13.87

5.9

6.1

12.52

12.22

mg/l

0.79

515

2653

(3014765) Yersinia sp identified in Stool by Organism specific culture

825

4358

1.34

13.61

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

460

2195

1.48

13.60

1.6

1.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

827

4371

1.34

13.59

1.2

—

(3044889) 12 lead EKG panel

17185

116222

1.11

13.30

5.3

4.7

0.66

1908.14

0.91

274

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

100

300

2.35

13.30

2.1

1.8

1.20

1.18

mmol/l

0.74

289

(3025941) Bacteria identified in Stool by Culture

1405

7994

1.25

13.11

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.48

12.89

1.6

1.9

—

(3028717) Thiamine [Mass/volume] in Blood

177

2.75

12.59

1.2

1.1

69.01

63.16

ug/l

1.22

177

(40768793) Breast Pathology biopsy report

375

3883

0.67

12.39

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

104

3.32

12.26

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

213

867

1.73

12.24

1.6

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

10162

67156

1.10

12.24

5.5

6.3

3.46

3.81

ug/l

0.49

8899

60269

(3012516) Albumin [Mass/volume] in Urine

8736

65655

0.91

12.18

3.5

3.6

64.09

49.13

mg/l

5.68

5844

42056

(3000330) Specific gravity of Urine by Test strip

1683

9838

1.22

12.17

4.3

3.7

1.02

ratio

4.97

1523

8931

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

222

2.51

12.11

1.1

—

(3022313) Gas panel - Capillary blood

1595

9291

1.22

11.94

3.7

4.0

—

(3010813) Leukocytes [#/volume] in Blood

23939

165203

1.14

11.81

37.6

29.4

7.14

6.87

e9/l

32.11

23282

160393

(3007461) Platelets [#/volume] in Blood

23931

165159

1.14

11.71

37.6

29.4

240.29

242.73

e9/l

6.33

23356

161086

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

111

3.17

11.69

1.1

1.2

51.33

19.33

—

(3035941) MCH [Entitic mass]

23932

165175

1.14

11.65

37.4

29.3

30.45

30.44

0.39

23571

162985

(3027923) C peptide [Moles/volume] in Serum or Plasma

230

971

1.67

11.61

1.4

1.3

1.19

1.22

nmol/l

0.11

165

717

(3026361) Erythrocytes [#/volume] in Blood

23932

165186

1.14

11.58

37.6

29.4

4.29

4.42

e12/l

270.73

23273

160327

(3024731) MCV [Entitic mean volume] in Red Blood Cells

23931

165181

1.14

11.56

37.5

29.3

91.95

91.70

13.18

23572

162988

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

23931

165183

1.14

11.55

38.3

29.9

38.70

40.05

59.23

23567

162921

(3000963) Hemoglobin [Mass/volume] in Blood

23933

165201

1.14

11.53

37.9

29.6

129.31

133.45

g/l

313.98

23581

163050

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

5.63

11.33

1.0

—

(3037756) Immunofixation for Serum or Plasma

892

4894

1.29

11.28

1.4

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

328

1528

1.52

10.99

2.2

2.0

1.52

3.63

u/field

0.73

184

819

(4281824) Cell count and differential, peritoneal fluid

163

1979

0.58

10.95

1.2

—

(3008898) HLA-B27 [Presence]

347

3551

0.68

10.83

1.0

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2153

13008

1.18

10.81

9.3

8.8

24.41

24.29

mmol/l

0.81

2085

12674

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

214

2.43

10.74

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1347

11420

0.82

10.66

1.3

—

(3033658) Prothrombin time (PT) actual/Normal

7079

46202

1.10

10.63

4.7

4.4

82.85

85.55

15.68

6904

45277

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1256

7237

1.23

10.48

2.7

3.4

2.51

6.44

ratio

1.59

756

4206

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

159

1912

0.58

10.33

1.1

0.60

1.56

u/ml

3.29

1044

(3013247) Albumin in CSF/Albumin in Serum or Plasma

202

2.44

10.23

1.2

1.1

8.03

9.09

mg/g

0.57

195

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.68

10.21

1.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1390

8119

1.21

10.15

2.8

3.4

43.52

46.89

mg/l

0.38

1138

6951

(3005322) IgE [Units/volume] in Serum or Plasma

1052

9092

0.81

10.06

1.4

1.3

312.15

260.21

u/ml

0.65

949

8378

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

214

923

1.63

10.03

2.1

2.0

15.97

16.22

nmol/l

0.17

199

854

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2868

22748

0.87

10.00

3.3

4.3

11.67

27.69

ug/l

6.01

2385

19043

(3052851) Hemolysis interference index of Serum or Plasma

962

5411

1.26

9.99

3.7

3.5

2.01

1.95

index

0.10

495

2731

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2787

17277

1.15

9.97

2.7

2.5

47.31

48.79

u/l

0.05

2304

14580

(3000012) Reticulocyte production index

617

3275

1.33

9.97

2.0

2.2

0.88

0.90

0.35

438

2283

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

209

2.39

9.96

1.1

—

(3044927) Protein electrophoresis panel - Urine

448

2262

1.40

9.93

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1767

10577

1.19

9.91

2.4

2.5

24.73

23.11

au/ml

0.20

878

(3034860) Kappa light chains.free [Mass/volume] in Serum

1389

8133

1.21

9.90

2.8

3.4

53.08

68.17

mg/l

1.17

1137

6965

(3017569) Oxygen content in Arterial blood

269

1239

1.53

9.57

2.3

2.2

15.99

15.63

0.99

269

1239

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

704

0.35

9.55

1.3

1.5

59.91

60.05

ug/l

0.01

588

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

434

4179

0.73

9.54

1.7

1.8

48.49

44.29

nmol/l

2.15

418

4016

(3010726) Horse dander IgE Ab [Units/volume] in Serum

105

1378

0.53

9.38

1.0

1.1

0.41

0.91

u/ml

2.41

705

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1620

9677

1.19

9.31

1.3

56.25

56.93

au/ml

0.04

630

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

519

4842

0.75

9.25

2.3

3.4

212.92

1071.14

u/ml

3.59

459

4379

(3013512) EKG study

9975

66461

1.09

9.19

4.6

4.1

0.90

0.73

1.87

179

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

127

485

1.84

9.15

1.3

1.5

15.65

16.31

pmol/l

0.55

404

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

305

3082

0.69

8.97

1.5

258.25

215.14

pmol/l

0.29

294

3002

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1007

5768

1.24

8.94

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

8907

59118

1.09

8.92

2.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

333

3310

0.70

8.92

1.9

181.32

198.72

pmol/l

3.08

294

3086

(3003888) Timothy IgE Ab [Units/volume] in Serum

131

1586

0.58

8.81

1.0

1.1

4.58

3.06

u/ml

0.51

787

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

602

0.33

8.80

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

295

1413

1.47

8.75

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

892

5057

1.25

8.70

1.5

—

(3037121) Protein [Mass/volume] in Urine

1147

6683

1.22

8.64

2.9

3.2

373.44

591.32

mg/l

1.91

477

3056

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1130

0.51

8.62

1.0

1.1

2.02

3.05

u/ml

0.57

500

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1028

5925

1.23

8.62

1.4

259.44

258.86

ug/g

0.03

603

3616

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

648

0.36

8.61

1.3

1.5

1.18

1.14

ratio

0.09

395

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

648

0.36

8.61

1.3

1.5

1.13

0.96

ratio

1.37

395

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

648

0.36

8.61

1.3

1.5

0.96

1.18

ratio

1.38

396

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

637

0.35

8.59

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

176

1968

0.63

8.56

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

110

2.82

8.54

1.0

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

419

3981

0.74

8.50

1.6

1.7

6.54

4.55

mg/l

1.39

342

3007

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

103

2.87

8.44

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

768

4296

1.26

8.42

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

490

4543

0.75

8.40

1.3

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5258

39914

0.91

8.33

3.3

3.6

0.79

0.82

ug/l

1.42

3846

28506

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1198

0.53

8.28

1.0

1.1

2.21

2.71

u/ml

0.18

589

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

265

2700

0.69

8.20

3.5

3.7

48.08

43.60

u/ml

0.14

254

2626

(3024891) Influenza virus A+B Ag [Presence] in Specimen

642

3525

1.29

8.20

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

130

1544

0.59

8.16

1.0

1.1

0.91

0.79

u/ml

0.13

667

(3043238) Trisomy 21 risk [Likelihood] in Fetus

557

0.33

8.15

1.3

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

666

3679

1.28

8.11

4.1

3.6

30.80

28.60

mg/l

0.76

491

2572

(3047352) Trisomy 18 risk [Likelihood] in Fetus

543

0.32

8.06

1.3

1.5

—

(3005033) Fetal Nuchal fold Thickness US

531

0.32

8.03

1.3

1.5

1.25

1.28

0.15

376

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

536

2883

1.31

8.00

1.9

2.2

32.45

32.46

0.02

526

2874

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21671

155206

0.91

7.96

6.2

6.5

2.42

2.55

mmol/l

92.34

19523

141824

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1025

0.51

7.95

1.0

0.27

0.22

u/ml

0.14

374

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.40

7.92

1.9

1.5

457.53

509.75

nmol/l

0.18

(3029634) Reagin Ab [Titer] in Serum by VDRL

330

1649

1.41

7.87

1.9

2.1

8.85

3.12

titre

0.58

(3050129) First trimester maternal screen panel - Serum or Plasma

791

0.44

7.86

1.5

1.4

—

(44790047) Parainfluenza type 1 nucleic acid detection

448

2359

1.34

7.76

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

448

2359

1.34

7.76

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

448

2359

1.34

7.76

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

448

2359

1.34

7.76

1.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

153

653

1.65

7.60

1.6

1.4

1440441.18

1550956.46

iu/ml

0.06

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

930

5385

1.22

7.50

1.3

—

(40757373) Influenza virus identified in Isolate

329

1.93

7.49

1.4

1.7

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

345

1.90

7.42

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

2815

21953

0.89

7.39

1.3

507.52

508.15

titre

0.01

641

4973

(3023511) Choriogonadotropin [Units/volume] in Urine

139

583

1.68

7.39

1.6

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

4.07

7.39

1.1

—

mmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

332

1681

1.39

7.37

1.6

30.85

25.33

u/ml

0.96

326

(3045142) Bone marrow Pathology biopsy report

252

2532

0.70

7.27

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1546

9404

1.17

7.18

2.2

2.4

7.56

7.45

g/l

1.80

1332

8519

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1352

8139

1.18

7.15

2.2

2.4

10.22

10.20

g/l

0.04

1119

7165

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1544

9397

1.16

7.12

2.2

2.4

4.18

g/l

0.02

1332

8523

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3946

25471

1.10

7.07

3.2

4.5

244.07

247.08

u/l

0.54

3627

24182

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1540

9382

1.16

7.02

2.2

2.4

3.75

3.72

g/l

0.33

1332

8500

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

557

0.38

7.01

1.5

1.7

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

119

488

1.72

6.89

1.6

0.43

0.38

ug/l

0.75

328

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

161

1744

0.65

6.88

1.7

1.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1449

8803

1.17

6.85

2.2

2.4

2.92

2.93

g/l

0.24

1237

7918

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

219

1042

1.48

6.84

1.8

2.0

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1545

9435

1.16

6.83

2.8

3.5

4.31

4.38

pmol/l

1.72

1328

8374

(3032057) Clostridioides difficile [Presence] in Stool

102

402

1.79

6.78

1.6

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

880

5124

1.21

6.76

1.5

1.6

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1808

14412

0.87

6.75

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

359

1872

1.35

6.70

2.7

2.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

468

2546

1.30

6.52

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

946

7901

0.84

6.47

2.6

3.5

234.82

2108.69

u/ml

3.67

790

6828

(4034850) Laboratory test

860

5022

1.21

6.43

13.8

12.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

198

936

1.49

6.41

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

198

936

1.49

6.41

1.3

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

935

0.54

6.38

1.2

1.3

128.30

173.25

pmol/l

2.32

935

(3045424) Erythrocytes [Presence] in Urine

1512

9279

1.15

6.27

2.2

0.00

0.13

estimate

0.66

367

2563

(3017509) Phencyclidine [Presence] in Urine

3.03

6.24

3.3

1.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

21038

150494

0.93

6.19

24.4

19.5

72.63

74.17

ml/min/173m2

22.85

19820

140503

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

441

0.35

6.14

1.5

1.6

61.89

59.56

ug/l

0.06

441

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1249

7570

1.17

6.12

2.8

0.37

0.35

iu/ml

0.92

714

4221

(3028679) Herpes simplex virus Ab [Presence] in Serum

143

641

1.57

5.94

1.1

1.2

—

(3017704) Immunofixation for Urine

243

1218

1.41

5.83

1.4

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

784

4588

1.21

5.78

2.3

2.4

189.39

109.25

ug/min

2.74

412

2639

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

882

5222

1.19

5.74

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

748

4366

1.21

5.68

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

201

979

1.45

5.66

2.1

2.2

26.20

26.85

umol/l

0.02

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

272

1399

1.37

5.62

1.3

48.24

65.56

titre

0.51

(40768443) Skin Pathology biopsy report

1073

8757

0.86

5.60

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

359

1.75

5.55

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

5.86

5.52

2.1

1.9

234.14

271.83

ug/l

0.19

(3007463) Buprenorphine [Presence] in Urine

5.86

5.52

4.6

11.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

278

1440

1.36

5.51

1.3

545.71

470.36

titre

0.11

110

(3004451) EKG impression Narrative

252

1287

1.38

5.45

1.3

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

186

1865

0.70

5.44

2.9

4.1

52.37

67.02

u/ml

0.43

178

1835

(3003740) Influenza virus B Ag [Presence] in Specimen

145

1521

0.67

5.41

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

146

673

1.53

5.40

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

641

3706

1.22

5.38

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

363

1966

1.30

5.32

1.3

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

329

1759

1.32

5.29

1.2

1.3

1.34

1.50

nmol/l

1.74

296

1589

(3002523) Influenza virus A Ag [Presence] in Specimen

147

1518

0.68

5.08

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

195

967

1.42

5.04

1.8

473.75

331.09

mu/l

2.00

159

760

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

540

4634

0.82

5.01

1.3

7.40

5.51

u/ml

0.20

455

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

516

4446

0.81

4.98

1.2

0.74

13.71

u/ml

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

5089

33684

1.08

4.98

1.3

1.67

1.79

u/ml

0.28

1199

8203

(3020682) Albumin/Creatinine [Ratio] in Urine

9134

66828

0.94

4.98

4.2

4.3

12.05

8.91

mg/mmol

5.18

5876

41384

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1052

0.62

4.97

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

324

0.33

4.96

1.1

1.3

—

(3025130) Human papilloma virus identified in Specimen

131

1376

0.67

4.96

1.8

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

306

1637

1.32

4.94

1.5

—

(3036180) Methadone [Presence] in Urine

7.74

4.93

2.5

—

(3051611) Lipemic interference index of Serum or Plasma

356

1945

1.29

4.92

3.7

3.6

12.54

12.99

index

0.34

202

1031

(3009508) Creatinine [Moles/volume] in Urine

9156

66955

0.94

4.88

3.6

3.5

6.92

7.18

mmol/l

7.46

7595

55362

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

542

4633

0.82

4.85

1.3

5.38

5.21

u/ml

0.03

698

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

253

2368

0.75

4.84

3.9

3.5

7.33

12.07

nmol/l

0.68

247

2300

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

346

3104

0.78

4.81

1.8

1.9

23.35

24.90

ug/l

0.15

332

3032

(3049717) Cytology report of Urine Cyto stain

1414

8810

1.14

4.78

2.6

2.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

23342

162132

1.08

4.77

13.9

13.7

23.70

25.45

u/l

14.70

22420

156536

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7989

53757

1.06

4.77

4.8

5.0

21.96

22.36

1.50

4079

29104

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1306

8096

1.14

4.77

2.3

2.6

1.04

0.96

g/l

0.28

1060

6877

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

209

2003

0.73

4.71

1.1

1.2

35.36

37.89

u/ml

0.06

110

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

3.01

4.70

1.0

1.1

—

(40768441) Liver Pathology biopsy report

124

1301

0.67

4.69

1.4

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

582

4920

0.83

4.66

1.3

38.63

38.43

u/ml

0.01

238

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

144

1466

0.69

4.65

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

269

1.78

4.60

1.1

—

(3051651) Icteric interference index of Serum or Plasma

207

1056

1.38

4.59

3.5

3.9

0.82

0.93

index

1.09

202

1030

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

227

2135

0.75

4.53

1.3

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

130

610

1.50

4.51

1.1

1806.73

1552.37

miu/ml

1.51

130

610

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

436

2479

1.24

4.37

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

21898

151873

1.07

4.31

6.0

5.9

6.21

6.08

mmol/l

30.88

19577

136970

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

558

3272

1.20

4.16

1.1

17.41

10.49

eliau/ml

0.22

248

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

946

0.64

4.14

9.3

3.6

13.64

13.26

3.71

935

(3004716) Salmonella sp identified in Stool by Organism specific culture

933

5711

1.15

4.14

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

117

550

1.50

4.07

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

17635

121631

1.05

4.02

34.0

25.5

330.68

331.44

g/l

23.02

17475

120931

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

536

3146

1.20

3.97

1.4

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

556

0.54

3.93

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

556

0.54

3.93

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

556

0.54

3.93

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

556

0.54

3.93

1.2

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

126

2.07

3.92

1.3

1.4

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

233

0.30

3.91

1.2

1.0

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

405

2323

1.23

3.81

1.4

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

157

1.93

3.79

1.5

1.6

1.79

0.82

mmol/l

0.81

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

108

1111

0.68

3.78

1.6

1.3

1.04

1.58

u/ml

0.51

668

(3005988) Vibrio sp identified in Specimen by Organism specific culture

405

2326

1.23

3.76

1.4

—

(3000285) Sodium [Moles/volume] in Blood

424

1.54

3.75

1.3

138.37

138.27

mmol/l

0.07

353

(3025468) Yersinia sp identified in Specimen by Organism specific culture

403

2315

1.23

3.74

1.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6723

45333

1.06

3.57

2.7

2.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2863

18789

1.08

3.50

1.8

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

419

2438

1.21

3.46

1.4

—

(36660697) Celiac disease serology panel - Serum

1885

12168

1.10

3.42

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

4.02

3.41

1.5

240.67

121.08

nmol/l

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

485

4040

0.84

3.41

1.2

1.88

5.63

u/ml

2.47

274

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

203

1856

0.77

3.41

1.2

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

519

3089

1.18

3.36

1.3

1.5

6.93

15.56

u/ml

2.19

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

3.66

3.35

1.1

1.6

11.63

47.84

e6/l

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

2.12

3.34

1.7

1.6

24.26

22.44

mmol/l

0.94

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

632

0.61

3.30

1.1

17.76

22.67

u/ml

0.57

193

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

415

2426

1.21

3.29

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

261

0.40

3.24

1.9

1.5

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

3.52

3.23

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

181

962

1.32

3.22

2.1

1.9

2.08

2.91

u/field

0.99

117

659

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

399

3359

0.83

3.19

1.3

1.2

42.61

47.55

u/ml

0.28

313

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

827

6581

0.88

3.17

2.0

1.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

439

2591

1.19

3.16

2.0

2.2

27.42

26.93

mg/l

0.06

137

948

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.98

3.14

1.3

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

187

1706

0.77

3.13

1.2

88.54

77.71

u/ml

0.27

(3038177) Helicobacter pylori Ab [Presence] in Serum

243

2146

0.79

3.11

1.4

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

104

507

1.44

3.11

1.2

11.04

14.51

pmol/l

0.61

188

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

620

3771

1.16

3.10

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

326

1874

1.23

3.08

1.4

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

453

2689

1.19

3.07

2.2

1.8

385.60

287.76

mu/l

4.13

410

2481

(3020876) Protein [Mass/time] in 24 hour Urine

460

2737

1.18

3.03

2.3

2.4

1.18

1.14

g/24h

0.12

234

1616

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

191

1730

0.77

3.03

1.7

1.8

4.76

4.27

mg/l

0.60

177

1659

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

333

2822

0.83

2.90

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

332

2813

0.83

2.89

1.5

1.6

0.73

0.85

g/l

1.28

248

2156

(3026389) Candida sp identified in Specimen by Organism specific culture

409

2421

1.19

2.88

1.5

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

854

6735

0.89

2.87

2.0

1.7

8.94

7.69

iu/ml

0.38

226

1525

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1112

8641

0.90

2.86

1.2

94.80

126.47

u/ml

2.13

364

2911

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

206

0.38

2.85

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

355

1.51

2.84

1.3

1.2

16.10

16.39

umol/l

0.22

313

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

106

529

1.41

2.83

4.4

6.8

60.00

72.52

3.54

422

(3012920) Ethanol [Mass/volume] in Serum or Plasma

4.22

2.79

1.8

1.4

1.37

2.29

g/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

197

1.68

2.75

1.6

1.7

42.09

49.04

umol/l

1.07

197

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

375

1.48

2.75

1.4

1.3

1.17

1.18

mmol/l

0.26

375

(3035715) Granulocytes [#/volume] in Blood

502

3040

1.16

2.71

3.3

4.53

4.26

e9/l

1.51

502

3031

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

184

1007

1.29

2.71

1.0

1.1

6.07

8.24

nmol/l

0.29

202

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

130

1.84

2.70

1.4

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

559

3414

1.15

2.70

1.7

1.5

0.84

0.87

nmol/l

0.38

459

2849

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

172

935

1.30

2.67

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

167

1.73

2.67

17.2

10.3

0.30

0.22

0.85

167

(3028433) Virus identified in Specimen by Culture

108

548

1.39

2.65

1.1

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

762

6016

0.89

2.64

2.0

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

779

0.69

2.59

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

628

0.66

2.59

1.8

2.1

18.39

396.93

ug/l

1.47

594

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

320

0.53

2.56

1.7

1.6

1.99

2.52

ug/l

0.44

183

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.14

2.52

1.1

1.0

157.00

169.27

pmol/l

0.09

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

412

1.43

2.51

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

495

0.62

2.50

1.0

0.58

0.68

u/ml

0.14

176

(1617658) Protocol used for examination of sentinel lymph nodes

123

1147

0.75

2.50

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

307

2580

0.83

2.50

2.4

2.6

38.47

1150.36

u/ml

2.21

302

2547

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

225

1.59

2.49

2.8

2.7

0.57

0.52

u/field

0.14

225

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

2.48

0.0

1.0

—

8.50

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

153

1383

0.78

2.47

3.9

3.7

157.26

171.70

nmol/l

0.11

147

1366

(3000034) Microalbumin [Mass/volume] in Urine

278

1615

1.21

2.46

2.8

3.1

24.47

48.14

mg/l

2.16

204

1170

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

356

1.46

2.45

1.3

1.2

1.11

56.04

mg/l

1.47

257

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

342

0.55

2.44

3.0

2.0

8.64

9.04

mg/l

0.14

287

(3001729) Color of Synovial fluid

135

1.77

2.43

1.4

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

177

1564

0.79

2.38

1.2

7.91

7.82

mmol/l

0.13

150

1300

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

133

711

1.32

2.38

1.7

1.6

4.29

5.72

nmol/l

0.38

113

616

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

156

0.41

2.36

1.2

1.6

—

(40768797) Stomach Pathology biopsy report

3436

25357

0.95

2.36

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

6657

48333

0.96

2.34

2.8

3.0

355.53

356.91

umol/l

0.43

5547

41683

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

213

1211

1.24

2.34

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

247

1427

1.22

2.33

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

234

1345

1.23

2.32

1.2

98.33

105.46

pmol/l

1.27

234

1345

(44813793) Dust mix specific IgE antibody measurement

106

996

0.75

2.31

1.0

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

234

1347

1.22

2.29

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

208

1183

1.24

2.28

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

155

852

1.28

2.27

1.2

3.6

65.43

600.18

mg/l

0.83

600

(3024263) Appearance of Synovial fluid

167

927

1.27

2.26

1.4

1.6

—

(3020491) Glucose [Moles/volume] in Blood

210

1197

1.24

2.26

1.8

2.0

7.54

7.21

mmol/l

0.72

155

820

(21494434) Karyotype in Bone marrow

234

1994

0.82

2.25

1.1

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

263

1537

1.20

2.22

2.5

2.1

3287.10

3663.37

u/l

0.08

571

(3004616) Nuclear Ab [Presence] in Serum

272

2281

0.84

2.21

1.3

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

257

0.52

2.18

4.6

3.4

147.20

129.66

ng/l

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

427

2606

1.15

2.16

1.5

—

(3014178) Parietal cell Ab [Units/volume] in Serum

5.86

2.14

1.0

61.80

52.83

u/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

190

1.59

2.13

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

631

4964

0.89

2.13

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

380

0.61

2.13

1.0

0.09

0.96

u/ml

0.67

110

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

213

1226

1.22

2.12

1.4

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

705

0.72

2.08

32.6

30.0

107.95

ug/l

0.00

593

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

591

3698

1.13

2.07

1.3

68.89

156.36

titre

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

116

1.76

2.07

1.4

1.6

1.09

0.74

0.31

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

363

2950

0.86

2.03

2.0

2.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

589

3693

1.12

2.01

1.3

182.45

264.48

titre

1.17

286

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

851

5444

1.10

2.00

1.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

459

0.66

2.00

1.0

4.22

1.05

u/ml

0.38

118

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

123

0.40

1.95

1.3

1.2

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.13

1.95

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

430

0.65

1.93

1.2

13.23

12.80

mm/h

0.06

430

(3010838) Calcium [Moles/time] in 24 hour Urine

497

3095

1.13

1.91

1.6

1.8

4.34

4.73

mmol/24h

1.82

414

2681

(3006245) CD3-CD19+ cells/cells in Blood

496

1.33

1.91

2.1

1.9

8.40

11.45

1.37

444

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

420

0.65

1.90

1.2

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

263

0.56

1.90

1.0

6.28

9.89

u/ml

—

153

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1045

6772

1.09

1.88

2.2

2.5

0.04

0.03

g/l

0.22

908

6076

(3023487) Leukocytes [#/volume] in Peritoneal fluid

811

0.75

1.86

1.7

1.9

2354.91

4115.25

e6/l

0.33

541

(3036048) Francisella tularensis Ab [Titer] in Serum

366

0.63

1.85

1.1

1.2

—

1010.67

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

218

1830

0.84

1.85

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

104

945

0.77

1.84

5.7

7.0

19.70

140.10

ug/l

1.98

610

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

313

0.61

1.83

3.1

3.3

7.12

7.86

mg/l

0.40

251

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

382

0.64

1.83

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

177

0.48

1.82

3.1

2.3

238.17

384.68

umol/l

0.64

168

(3023323) Follitropin [Units/volume] in Serum or Plasma

332

2688

0.87

1.81

1.5

1.4

30.74

30.47

iu/l

0.05

273

2274

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

11850

81823

1.03

1.80

3.0

—

estimate

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

174

1486

0.82

1.79

1.1

94.66

94.96

0.05

159

1374

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

257

1.45

1.78

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

600

4676

0.90

1.77

2.3

2.4

206.39

208.56

0.22

567

4433

(3037692) Legionella sp identified in Specimen by Organism specific culture

730

0.75

1.74

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

171

1457

0.82

1.73

1.1

3.91

3.93

eliau/ml

0.00

465

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

104

566

1.29

1.73

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

400

2478

1.14

1.71

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

330

1.39

1.71

2.1

1.8

1.34

1.08

e9/l

0.07

163

(3043410) Blood group antigens tested for on Red Blood Cells

524

1.30

1.71

1.6

2.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

606

4709

0.90

1.70

1.7

1.9

12.86

12.37

mg/l

0.25

552

4358

(44786800) Granulocytes/Leukocytes in Body fluid

283

1.42

1.70

1.3

16.63

24.64

1.30

225

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

568

3595

1.11

1.70

1.5

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

479

3769

0.89

1.69

4.8

417.87

1354.19

iu/ml

1.23

561

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

21430

149449

1.04

1.69

7.9

7.4

41.24

40.17

mmol/mol

43.32

19488

137622

(3020393) Adenovirus Ag [Presence] in Stool

157

1.57

1.69

1.1

—

(3033099) Centromere Ab [Titer] in Serum

441

0.69

1.68

1.1

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

532

1.30

1.67

1.3

70.89

56.74

3.69

460

(3024316) Viscosity of Plasma

1.78

1.67

2.0

1.60

1.79

mpas

0.68

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

142

1227

0.81

1.67

1.1

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

137

1188

0.81

1.66

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

313

0.63

1.66

2.2

1.7

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

17945

124796

1.03

1.65

31.3

24.1

14.01

13.87

33.32

17744

123073

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

250

1.44

1.64

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

188

0.52

1.64

1.0

1.1

16.80

35.90

iu/ml

1.52

188

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

281

2281

0.86

1.62

1.1

1.58

1.56

g/l

0.40

255

2057

(3038026) Centromere Ab [Units/volume] in Serum

171

1445

0.83

1.61

1.2

38.81

50.39

u/ml

—

(3003577) Lead [Moles/volume] in Blood

1.78

1.60

1.2

0.10

0.12

umol/l

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

806

0.78

1.59

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

113

0.44

1.58

1.0

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

650

5010

0.91

1.57

2.1

89.47

89.96

0.21

623

4819

(3006576) Bicarbonate [Moles/volume] in Blood

118

662

1.25

1.57

6.1

6.6

24.99

24.94

mmol/l

0.05

106

591

(3000475) Leukocytes [#/volume] in Synovial fluid

782

5052

1.09

1.57

1.6

17647.54

14996.62

e6/l

0.60

552

3558

(3010144) Erythrocytes [#/volume] in Synovial fluid

307

1882

1.15

1.56

1.3

1.4

146825.05

157675.14

e6/l

0.09

191

1265

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

700

0.76

1.55

1.7

1.8

5718.08

15587.64

e6/l

1.39

365

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

604

0.74

1.55

1.1

2.94

5.32

u/ml

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

132

0.48

1.54

1.0

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

141

1206

0.82

1.52

1.1

1.2

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

146

842

1.22

1.52

1.2

1.5

63.87

65.67

0.24

113

697

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

714

0.77

1.52

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

147

1248

0.83

1.48

1.1

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

240

1954

0.86

1.47

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

108

0.46

1.47

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

154

1299

0.83

1.45

4.5

5.6

76.60

107.09

u/ml

0.29

411

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

230

1875

0.86

1.44

1.1

113.96

116.12

0.45

203

1665

(3035947) Staphylolysin Ab [Units/volume] in Serum

156

912

1.20

1.44

1.1

3.30

4.29

iu/ml

—

(40765096) Chromosome analysis panel by Banding

643

0.76

1.42

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

308

2457

0.88

1.42

1.9

2.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

148

1249

0.83

1.41

1.1

1.2

—

(3036489) Thrombin time

966

6327

1.08

1.41

1.9

2.0

21.19

21.51

0.65

881

5717

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

298

2380

0.88

1.40

1.3

0.19

0.21

nmol/l

1.08

242

1917

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.40

1.40

3.0

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

178

1476

0.85

1.40

1.1

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.06

1.38

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

934

6116

1.08

1.38

2.3

2.5

0.00

g/l

-0.00

845

5722

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3106

22655

0.96

1.38

5.1

5.5

33.95

33.05

3.99

1984

14500

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

347

2741

0.89

1.38

1.3

0.32

0.24

nmol/l

0.55

211

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

103

897

0.81

1.36

1.0

1.1

12.44

10.57

iu/ml

0.23

192

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

998

6557

1.07

1.35

2.2

2.5

0.00

g/l

0.17

848

5734

(40762887) Creatinine [Moles/volume] in Blood

155

1.50

1.35

1.5

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

157

1311

0.84

1.35

1.1

—

(4268621) Lupus anticoagulant assay

176

1455

0.85

1.34

2.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

453

0.73

1.34

2.5

1.9

2.85

5.64

ug/l

1.18

318

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

284

1756

1.14

1.33

1.4

13.71

13.25

u/l

0.47

272

1695

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

1.81

1.33

1.0

0.15

0.21

u/ml

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

287

1776

1.14

1.32

1.5

21.18

29.40

4.47

180

1065

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

126

0.50

1.31

4.9

6.2

11.33

8.25

—

126

(40761995) Spermatozoa Progressive [#/volume] in Semen

126

0.50

1.31

2.4

3.1

33.44

44.36

—

126

(3007147) Virus identified in Stool by Electron microscopy

2.93

1.29

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

2.93

1.29

1.2

1.1

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

263

1.36

1.29

2.8

2.6

1.94

2.39

0.71

257

(3002619) Bacteria identified in Specimen by Culture

491

1.26

1.28

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1959

13158

1.05

1.28

3.0

2.9

10.70

10.65

g/l

0.17

1770

12136

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

510

1.26

1.28

2.0

1.8

29.70

30.24

0.12

473

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

2.34

1.28

1.4

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

192

1158

1.17

1.27

1.1

1.0

296.28

291.59

mg/l

0.37

172

1038

(40759836) Histone Ab [Presence] in Serum by Immunoblot

155

1286

0.85

1.26

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.71

1.25

2.8

4.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

223

1.39

1.24

1.8

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

315

0.69

1.23

1.3

1.8

7.55

179.29

pmol/l

0.59

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

737

0.80

1.22

1.3

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

461

3557

0.91

1.21

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

222

1786

0.87

1.21

1.1

0.97

3.17

—

154

(3023383) Lactate [Moles/volume] in Pleural fluid

130

763

1.20

1.2

1.3

3.90

3.36

mmol/l

0.86

117

705

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

774

0.81

1.20

1.6

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

774

0.81

1.20

1.6

1.9

—

(4195642) Thrombophilia screening test

233

1864

0.88

1.18

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.92

1.17

1.1

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

216

1736

0.87

1.17

1.2

1.4

6.96

6.94

g/l

0.02

147

1233

(3028192) IgG subclass 2 [Mass/volume] in Serum

216

1736

0.87

1.17

1.2

1.4

2.78

2.91

g/l

0.43

149

1234

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

410

1.27

1.17

2.4

7.49

7.63

mmol/l

0.14

259

(3024139) IgG subclass 3 [Mass/volume] in Serum

216

1734

0.87

1.16

1.2

1.4

0.38

0.43

g/l

1.43

151

1231

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.44

1.15

1.0

2.66

7.75

u/ml

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

343

2677

0.90

1.15

1.3

5.90

2.02

nmol/l

0.33

324

2565

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

251

1.35

1.14

1.1

1.2

1727.13

130.81

ng/l

0.52

171

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

147

878

1.18

1.13

2.4

1.7

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

136

807

1.19

1.13

1.5

15.77

23.23

umol/l

3.59

128

741

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

269

2125

0.89

1.13

1.2

5.72

4.13

u/ml

0.45

782

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

286

2250

0.89

1.12

3.5

3.6

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.88

1.11

2.3

4.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

774

0.82

1.11

1.1

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

122

1.50

1.11

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

495

3196

1.09

1.10

1.3

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

464

1.24

1.10

1.5

1.3

3.06

3.15

umol/l

0.10

406

(3015171) Extractable nuclear Ab [Units/volume] in Serum

810

6076

0.94

1.09

1.3

1.2

1.30

0.81

u/ml

0.42

502

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

127

1055

0.85

1.09

1.6

1.4

0.25

0.24

nmol/l

0.03

738

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2357

17187

0.96

1.08

1.6

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

236

1.34

1.07

1.5

1.9

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.83

1.05

1.0

—

(3033086) Enterovirus Ab [Titer] in Serum

1.83

1.05

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

369

0.74

1.05

1.1

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

2.14

1.05

1.3

1.5

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

237

1.34

1.04

1.2

1.3

86.90

106.01

ug/l

0.48

144

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1166

7780

1.06

1.03

1.1

1.78

7.92

u/ml

0.72

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

994

7392

0.94

1.03

1.5

1.8

38.20

38.91

u/l

0.46

835

6376

(3002331) Protein [Mass/volume] in Peritoneal fluid

518

0.79

1.02

1.4

1.3

24.70

41.57

g/l

0.85

412

(21494890) Protein electrophoresis panel - 24 hour Urine

373

2387

1.10

1.02

1.7

2.1

—

(3009871) Measles virus Ab [Titer] in Serum

423

0.76

1.02

1.6

4977.78

3273.25

titre

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.65

1.02

1.4

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

816

5391

1.07

1.01

2.7

2.9

1.75

1.74

mg/l

0.13

701

4848

(3034274) Bile acid [Moles/volume] in Serum --fasting

144

869

1.17

1.01

1.4

1.6

14.20

10.40

umol/l

0.43

104

619

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

563

0.80

1.00

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

483

1.22

1.00

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

130

779

1.17

1.00

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

137

1.44

1.00

1.1

9.29

10.53

u/l

0.20

137

(44806071) Cardiolipin IgM antibody measurement

161

1.40

0.99

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

345

1.26

0.98

2.8

14.98

14.62

ml/dl

0.44

324

(40758292) HTLV I+II Ab panel - Serum

284

0.72

0.98

1.2

1.3

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.98

0.0

2.8

—

31.88

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

823

0.84

0.98

1.5

9.54

10.49

ug/l

0.19

753

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.97

0.96

1.3

1.6

—

260840.00

—

(3044007) Cell count panel - Peritoneal fluid

683

0.82

0.96

1.7

1.9

—

(3020618) Glucose [Moles/volume] in Synovial fluid

1.59

0.95

1.1

1.0

4.97

5.20

mmol/l

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.65

0.95

1.6

1.36

1.39

mg/l

—

(4062490) Immunoglobulin typing, IgG

215

1698

0.89

0.94

1.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

251

1584

1.12

0.93

2.1

2.3

705.29

666.30

0.64

150

1029

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

475

1.21

0.93

1.4

1.3

30.50

36.95

0.75

316

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

768

5729

0.94

0.91

1.6

1.4

17.59

14.35

iu/ml

0.19

123

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

315

2431

0.91

1.1

1.2

3.91

7.55

u/ml

0.72

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

172

0.65

0.90

1.2

1.1

44.59

66.79

u/ml

1.18

167

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

382

1.23

0.89

1.1

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

474

3590

0.93

0.89

3.3

3.7

1.55

1.58

0.05

414

3195

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

213

0.69

0.89

10.8

8.2

0.33

0.44

umol/l

0.38

191

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

162

999

1.14

0.88

2.0

2.3

471.32

552.83

e6/l

0.87

127

823

(3016750) Collection duration of Urine

183

1138

1.13

0.88

2.1

510.72

498.99

min

0.85

119

804

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.87

0.87

3.8

5.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

638

4208

1.07

0.87

1.4

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

252

1.28

0.85

1.0

1.1

18.35

19.70

u/l

0.22

164

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1052

7047

1.05

0.85

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

387

0.78

0.85

1.1

—

(3035880) pH of Pleural fluid

213

1341

1.12

0.84

1.2

1.3

7.40

0.10

161

950

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

779

0.85

0.84

1.6

1.9

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

107

1.45

0.83

1.0

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

183

1143

1.13

0.83

1.6

6.53

7.21

u/l

0.25

137

915

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

112

676

1.17

0.83

2.5

2.6

0.60

0.62

mmol/l

0.98

112

676

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

161

998

1.13

0.83

1.1

—

0.62

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2001

14545

0.96

0.83

2.8

3.0

60.28

ml/min/173m2

0.00

932

6420

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

1288

0.88

0.83

2.2

2.3

17.45

28.42

iu/ml

1.15

199

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

294

2263

0.91

0.82

1.3

—

nmol/l

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

1.92

0.82

2.2

2.8

2.29

3.90

mu/l

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

250

0.73

0.82

1.2

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

258

0.74

0.82

1.1

1.2

5.23

129134.85

nmol/l

0.72

206

(3006922) Hepatitis E virus Ab [Presence] in Serum

187

1171

1.12

0.82

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

399

1.22

0.82

1.1

1.2

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.81

0.0

1.0

—

0.04

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

0.00

0.81

0.0

1.1

—

1.09

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.81

0.0

1.0

—

0.03

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.54

0.81

1.2

1.1

238.25

293.54

nmol/l

0.60

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

676

0.84

0.80

1.5

1.8

103621.67

24799.82

u/ml

0.41

112

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

542

1.18

0.80

1.1

1.40

16.19

u/ml

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

193

1.31

0.79

1.2

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

159

989

1.13

0.79

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

347

2644

0.92

0.79

1.5

1.4

161.98

155.31

au/ml

0.53

785

(4133840) Spirometry

343

0.78

1.3

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

393

2978

0.93

0.78

1.4

22.82

20.16

u/ml

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

159

990

1.13

0.78

2.2

234.46

93.11

ug/min

0.59

222

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

103

1.43

0.77

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

497

3732

0.94

0.77

1.5

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

303

2317

0.92

0.76

1.2

1.3

166.55

220.36

miu/ml

1.23

799

(3001893) Eosinophils/Leukocytes in Pleural fluid

120

736

1.15

0.74

1.3

1.5

2.98

2.37

0.32

618

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

573

1.17

0.73

1.3

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

261

2005

0.91

0.73

1.1

52.12

22.53

au/ml

1.01

303

(3011544) Albumin [Mass/volume] in Pleural fluid

252

1.26

0.73

1.2

15.75

17.34

g/l

0.66

233

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1371

10005

0.96

0.72

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

390

2945

0.93

0.72

1.4

10.54

11.04

u/l

0.30

298

2352

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

678

5029

0.95

0.72

1.6

1.5

10.44

4.34

iu/ml

0.38

168

1039

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

291

0.77

0.71

1.0

1.1

566.67

848.44

titre

—

(3013762) Body weight Measured

1.76

0.71

1.0

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

100

809

0.87

0.70

1.3

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1161

7847

1.04

0.68

2.7

—

(3041806) Other cells [#/volume] in Blood by Manual count

111

0.63

0.68

1.7

1.5

0.40

0.49

e9/l

—

111

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

391

2942

0.93

0.67

2.3

2.4

524.50

6129.80

u/ml

1.13

188

(3010503) CD19 cells [#/volume] in Blood

135

1067

0.89

0.67

2.4

2.3

390.98

402.31

e6/l

0.02

129

1026

(3012565) Volume of 24 hour Urine

147

923

1.12

0.66

1.8

2.2

1948.24

1863.98

0.27

113

803

(40762814) Titanium [Mass/volume] in Blood

411

0.82

0.66

2.2

2.4

3.23

3.40

ug/l

0.17

152

(3000494) Fungus identified in Specimen by Culture

3079

21167

1.03

0.65

1.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

316

2061

1.08

0.65

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

159

1005

1.11

0.64

1.2

—

(40758358) Immune stain study

0.59

0.63

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

120

1.35

0.63

1.0

0.15

0.02

u/ml

0.86

120

(3017143) Hepatitis C virus Ab [Presence] in Serum

2152

14732

1.03

0.63

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

136

1068

0.89

0.62

1.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

136

1068

0.89

0.62

1.5

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

136

1068

0.89

0.62

1.5

1.7

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.62

0.0

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

237

0.77

0.61

3.1

2.6

69.14

74.03

pmol/l

0.10

215

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

369

0.82

0.61

1.0

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

227

1.24

0.61

5.6

5.5

48.09

49.91

ug/min

0.06

190

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

784

0.88

0.61

8.1

4.9

4001.83

506.16

u/ml

0.56

100

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.50

0.61

39.2

10.5

107.46

105.20

g/l

0.30

(3009992) Blasts/cells in Bone marrow

0.00

0.61

0.0

1.6

—

15.94

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

525

1.15

0.61

1.6

1.4

411.36

223.74

nmol/24h

0.25

525

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

183

1412

0.91

0.60

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

382

1.18

0.60

1.1

1.3

0.60

1.34

mmol/l

1.69

255

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

402

3001

0.94

0.58

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

172

1.27

0.57

1.2

1.4

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.57

1.0

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

542

1.14

0.56

1.2

1.4

22.12

20.96

0.15

462

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

799

5852

0.96

0.55

1.6

35.74

24.76

u/ml

0.99

1100

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.54

0.55

1.0

0.15

0.11

u/ml

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

340

1.18

0.55

1.1

1.3

32.70

261.48

u/l

1.02

245

(3009015) Lactate [Moles/volume] in Synovial fluid

240

0.79

0.54

1.2

1.3

5.70

6.71

mmol/l

0.44

117

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

1.45

0.54

1.6

1.56

2.55

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.45

0.54

1.6

4.76

2.32

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.45

0.54

1.6

1.41

2.17

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

1.45

0.54

1.6

4.33

1.16

mg/l

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

1.45

0.54

1.6

2.72

3.75

mg/l

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.45

0.54

1.0

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.45

0.54

1.6

1.39

2.32

mg/l

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

394

2614

1.06

0.53

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.39

0.53

1.2

1.7

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

509

3402

1.05

0.53

1.1

11.01

3.38

—

252

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

327

2448

0.94

0.53

1.2

1.3

289.97

295.42

pmol/l

0.10

257

2046

(3017732) Neutrophils [#/volume] in Blood

3128

21577

1.02

0.53

3.7

3.3

5.04

4.78

e9/l

0.73

2530

18042

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

734

4957

1.04

0.50

1.9

1.5

0.23

0.24

g/l

0.43

693

4697

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

363

1.16

0.50

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

314

0.83

0.50

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

129

821

1.11

0.50

1.9

2.0

95.01

96.54

0.20

120

781

(3002621) Streptococcal DNAse B [Units/volume] in Serum

163

1.25

0.50

1.0

1.1

217.33

210.62

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

138

1066

0.91

0.50

1.4

1.7

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

158

1017

1.09

0.49

1.4

1.3

27.37

30.84

u/l

0.72

127

839

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

338

1.17

0.49

1.5

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

320

0.83

0.48

11.4

12.2

5.72

5.25

mmol/l

0.33

320

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

531

0.87

0.48

2.1

2.0

15.44

44.68

u/l

3.69

497

(3036782) Glucose [Moles/volume] in Pleural fluid

357

2372

1.06

0.48

1.3

1.4

6.49

6.35

mmol/l

0.43

329

2227

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

254

1.19

0.48

2.6

2.7

49.58

64.27

mg/l

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

227

0.81

0.47

2.0

1.5

—

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

133

0.74

0.47

1.4

1.3

1.27

0.87

ml/s/173m2

—

(4212803) Bone marrow aspirate examination

197

1.21

0.46

1.1

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

121

1.28

0.46

1.4

1.6

0.85

0.78

umol/l

0.10

(3016228) CD19 cells/cells in Blood

691

0.89

0.45

2.3

1.9

8.69

8.08

0.14

670

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

186

1213

1.08

0.44

1.2

10.36

9.48

mmol/l

1.54

170

1135

(40765089) Chromosome analysis panel - Blood by G-banded

171

0.78

0.44

1.1

1.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

363

2421

1.05

0.44

1.5

66.00

59.58

2.50

228

1504

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

345

2299

1.06

0.44

1.1

66.96

571.69

iu/ml

0.89

404

(3047189) Immunofixation for 24 hour Urine

139

1064

0.92

0.44

1.5

1.7

—

(3034426) Prothrombin time (PT)

429

0.87

0.43

1.2

28.64

28.39

0.10

429

(3014891) Appearance of Pleural fluid

329

1.15

0.43

1.4

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

167

1086

1.08

0.43

1.1

80.06

86.04

u/l

0.65

143

953

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

369

1.14

0.43

1.2

1.5

9.73

11.13

0.16

191

(3001218) Citrate [Mass/time] in 24 hour Urine

1.60

0.43

1.6

1.5

307.20

425.41

mg/24h

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

263

1740

1.06

0.43

1.4

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

263

1740

1.06

0.43

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

263

1740

1.06

0.43

1.4

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

356

1.15

0.43

1.3

1.2

35.43

70.13

mu/l

2.54

260

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

262

0.83

0.42

1.6

1.2

50.83

41.61

mg/l

0.45

228

(3013005) Retinol [Moles/volume] in Serum or Plasma

609

1.11

0.42

1.7

2.06

2.00

umol/l

0.27

561

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.42

0.0

1.3

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.42

0.0

1.3

—

0.56

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

129

1.25

0.42

1.4

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1445

10409

0.97

0.42

2.1

2.0

1.60

1.35

g/l

1.81

1281

9476

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.42

0.0

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.53

0.41

1.4

1.0

227.00

274.04

u/ml

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.37

0.41

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

575

0.89

0.41

1.3

1.4

12.36

14.38

g/l

1.04

441

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

312

2079

1.06

0.41

1.2

62.61

62.15

u/l

0.04

271

1810

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

10.62

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

5.32

—

(3007566) Smooth muscle Ab [Titer] in Serum

659

4469

1.04

0.40

1.2

110.55

144.60

titre

0.79

374

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.67

0.40

1.1

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

175

1.21

0.40

3.5

5.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

747

5080

1.03

0.40

1.6

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

165

1078

1.08

0.40

1.1

23.96

25.51

u/l

0.20

139

943

(44806420) Estimation of glomerular filtration rate

164

1239

0.93

0.39

2.8

2.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

213

1406

1.07

0.39

3.5

2.8

34.18

31.29

mg/l

0.45

166

1029

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

279

2070

0.95

0.38

1.3

1.2

3.82

4.03

u/ml

0.12

131

963

(3042631) Mycobacterium sp identified in Specimen

418

3069

0.96

0.38

2.6

2.8

—

(3044009) aPTT.lupus sensitive (LA screen)

112

1.26

0.38

1.2

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

104

668

1.09

0.38

1.2

1.4

23.06

19.62

0.64

596

(3022475) Manganese [Moles/volume] in Blood

0.69

0.37

1.3

0.16

umol/l

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

387

1.13

0.37

1.2

1.1

0.76

0.66

umol/24h

0.53

174

(3017354) Segmented neutrophils/Leukocytes in Blood

319

2355

0.95

0.37

2.8

3.7

58.22

58.44

0.06

260

2011

(40768806) Pleura Pathology biopsy report

366

2691

0.96

0.36

1.4

1.6

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

103

0.75

0.35

1.8

2.5

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

283

1.14

0.35

1.2

1.4

70.34

73.26

0.24

241

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

613

4170

1.03

0.34

1.7

1.8

15.41

8.61

iu/l

0.26

224

1504

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

172

0.82

0.34

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

370

1.12

0.34

4.7

6.2

8.89

8.47

mmol/l

0.52

370

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

187

0.83

0.34

1.0

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

725

5250

0.97

0.34

2.4

2.3

3.65

3.64

g/l

0.07

691

5026

(3020650) Glucose [Presence] in Urine

518

1.10

0.33

2.8

1.6

0.00

0.04

estimate

2.10

518

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.30

0.33

1.1

1.2

1.49

1.24

iu/ml

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

287

1924

1.05

0.33

1.2

1.3

17.31

12.99

u/l

1.13

262

1782

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

252

1863

0.95

0.33

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

363

2448

1.04

0.32

1.2

1.4

458.63

433.98

u/l

0.10

340

2330

(3023436) Glucagon [Mass/volume] in Serum or Plasma

117

0.78

0.32

1.4

1.8

197.00

198.42

ng/l

0.04

105

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

155

1021

1.07

0.32

2.1

2.4

225.93

243.06

e6/l

0.54

132

898

(3017315) Amylase [Enzymatic activity/volume] in Urine

141

926

1.07

0.32

1.2

232.92

353.58

u/l

1.01

128

854

(3034891) Synovial lining cells/cells in Synovial fluid

144

947

1.07

0.32

1.5

3.54

3.88

0.12

195

(3019768) Coxiella burnetii Ab [Presence] in Serum

101

0.77

0.32

1.0

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

746

5101

1.03

0.31

1.9

1.5

1.17

1.18

g/l

0.68

707

4856

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

283

0.87

0.31

1.3

1.2

93.09

80.52

0.53

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

173

1146

1.06

0.31

2.1

1.9

15.79

16.65

0.47

168

1107

(3034770) Mitochondria Ab [Titer] in Serum

650

4437

1.03

0.31

1.2

627.14

897.01

titre

0.59

117

(37208534) Antinuclear antibody arbitrary concentration in serum

497

0.91

0.31

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.30

0.30

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

962

6924

0.98

0.30

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

2643

18833

0.99

0.30

2.0

2.2

165.03

153.97

ug/g

0.70

1997

14744

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

168

1.17

0.30

2.0

3.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

406

0.90

0.28

1.7

1.8

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

184

1363

0.95

0.28

1.2

212.50

160.86

titre

0.35

233

(3036670) Protein [Mass/volume] in Synovial fluid

102

667

1.08

0.28

1.2

1.3

39.88

40.18

g/l

0.08

333

(3008757) Leukocyte morphology finding [Identifier] in Blood

317

2143

1.04

0.27

3.7

3.8

—

(40768446) Kidney Pathology biopsy report

613

1.08

0.27

1.4

1.6

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

184

1362

0.95

0.27

1.2

125.00

168.09

titre

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

0.79

0.26

2.0

1.3

1.40

1.04

u/field

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

579

0.92

0.26

2.4

1.8

1.97

1.72

ratio

0.60

557

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.66

0.26

1.0

10.45

4.61

u/ml

—

(3007164) IgA [Mass/volume] in Serum or Plasma

4224

29971

0.99

0.26

1.6

1.5

2.77

2.61

g/l

3.00

2321

17142

(3041918) Cholesterol [Moles/volume] in Pleural fluid

479

1.09

0.26

1.1

1.2

1.62

1.54

mmol/l

0.25

304

(3029396) Erythrocyte agglutination [Presence] in Blood

113

0.81

0.26

1.6

2.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

527

3602

1.03

0.25

1.3

1.5

31.27

40.53

g/l

0.56

476

3260

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.23

0.25

1.4

1.6

0.80

0.23

u/l

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

146

972

1.06

0.25

3.0

2.6

38.68

37.25

0.37

543

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

135

0.83

0.24

1.0

1.1

0.46

0.65

u/ml

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.71

0.24

1.2

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

328

0.90

0.24

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

119

1.18

0.24

1.8

5.7

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

119

1.18

0.24

1.1

107.20

98.42

titre

0.24

119

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

192

1.14

0.24

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

192

1.14

0.24

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

192

1.14

0.24

1.1

1.2

—

(3023419) Bacteria identified in Sputum by Culture

409

2789

1.03

0.24

2.4

2.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

466

0.92

0.23

1.3

1.5

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.75

0.23

1.0

1.1

—

25.00

—

(3036525) Urea [Moles/time] in 24 hour Urine

120

1.17

0.22

3.9

3.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

171

0.86

0.22

1.1

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

126

0.84

0.22

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

107

1.18

0.22

1.1

37.23

112.76

u/l

0.64

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

162

1086

1.05

0.22

2.2

2.3

0.65

e9/l

0.04

150

1023

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.80

0.22

1.4

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

178

0.87

0.22

1.1

1.6

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.22

0.0

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.22

0.0

1.3

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.21

0.0

1.1

—

2.56

—

(3032868) Hemoglobin electrophoresis panel in Blood

110

0.83

0.21

1.7

1.5

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

1.24

0.20

1.3

1.1

—

23.78

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

115

1.16

0.20

1.1

1.75

1.22

u/ml

0.11

(3009677) Dengue virus Ab [Presence] in Serum

1.21

0.20

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

182

1.12

0.19

1.8

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

177

1196

1.04

0.19

1.2

30.50

28.45

u/l

0.16

148

990

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

101

0.84

0.18

1.1

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

116

1.15

0.18

1.1

1.3

0.09

0.06

g/l

1.13

(3025159) Blasts/Leukocytes in Blood

2311

16402

0.99

0.18

4.4

0.30

0.34

0.11

599

4602

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

466

0.94

0.18

1.2

1.3

0.32

0.31

g/l

0.12

376

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

473

0.94

0.17

2.2

2.8

1.98

1.92

ratio

0.10

430

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.12

0.17

1.0

1.1

1.71

2.73

—

(1175426) CD3 cells/Lymphocytes in Blood

178

1207

1.04

0.17

2.2

1.9

72.12

70.92

0.44

168

1145

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.17

0.16

1.0

1.3

—

(3026470) Cobalt [Mass/volume] in Blood

199

1445

0.97

0.16

2.0

2.2

2.75

3.83

ug/l

2.21

185

1337

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.10

0.16

1.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

167

1133

1.04

0.16

3.4

3.9

—

(21491868) Cryoglobulin [Mass/volume] in Serum

650

1.05

0.16

1.2

1.25

0.35

g/l

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

114

0.86

0.15

1.9

2.7

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.84

0.15

1.2

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.81

0.15

1.0

1.6

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

159

1.11

0.14

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

176

1277

0.97

0.14

1.1

—

(4015189) Microbial culture of sputum

576

0.95

0.14

2.1

2.4

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

412

1.06

0.14

1.2

242.50

272.67

pmol/l

0.45

291

(3011412) CD3 cells [#/volume] in Blood

225

1540

1.03

0.13

2.2

1105.63

1151.37

e6/l

0.22

195

1395

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.86

0.13

7.3

8.8

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

481

0.95

0.13

1.0

1.1

99.66

95.06

0.44

357

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

170

1161

1.03

0.12

2.3

1.9

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

127

1.11

0.12

1.3

1.2

3239.87

3828.21

ng/l

0.17

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

191

0.92

0.11

1.0

1.1

7.77

21.37

iu/ml

1.91

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.17

0.11

1.0

1.1

—

(3017181) Myelocytes/Leukocytes in Blood

2455

17160

1.01

0.10

4.2

4.3

0.96

0.97

0.03

781

5605

(3025577) Chromium [Mass/volume] in Blood

194

1395

0.98

0.10

2.1

2.2

1.87

2.30

ug/l

1.56

159

1165

(3006567) Chloride [Moles/time] in 24 hour Urine

1.10

0.10

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.13

0.09

1.2

1.5

—

(3016330) Potassium [Moles/time] in 24 hour Urine

225

0.94

0.09

1.4

1.2

—

86.59

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

177

1.07

0.09

1.0

1.2

1.89

1.69

umol/24h

0.39

177

(3007733) Chloride [Moles/volume] in Urine

1.08

0.09

1.0

1.2

83.00

79.94

mmol/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

253

0.94

0.08

1.1

0.32

1.00

u/ml

0.92

118

(3019174) dRVVT (LA screen)

109

1.10

0.08

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.78

0.08

1.0

0.21

0.03

u/ml

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.09

0.08

8.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.09

0.08

1.4

1.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.07

0.08

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.06

0.07

1.3

1.2

23.42

61.32

umol/24h

—

(3042733) HLA Ab [Presence] in Serum

414

1.04

0.07

4.7

5.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

451

0.97

0.07

1.5

1.6

104.25

114.52

ug/l

0.32

374

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

1.12

0.07

1.1

1.20

0.93

u/field

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1204

8415

1.01

0.07

1.4

1.6

18.57

17.58

iu/ml

0.05

191

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.87

0.07

1.3

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

0.87

0.07

1.0

1.2

—

22.41

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

498

1.03

0.07

13.1

7.5

5.87

5.93

kpa

0.22

428

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

358

2546

0.99

0.07

1.2

280.72

277.97

u/ml

0.06

211

1557

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

131

1.07

0.06

1.1

6.22

mmol/l

0.02

131

(3003129) Base excess in Capillary blood by calculation

355

2524

0.99

0.06

2.2

2.4

1.06

0.40

mmol/l

2.54

333

2441

(3020961) Endomysium IgA Ab [Titer] in Serum

905

6321

1.01

0.06

1.1

175.56

183.24

titre

0.03

161

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

125

897

0.98

0.06

1.9

2.0

38.51

39.90

g/l

1.84

125

897

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

279

0.96

0.06

1.2

82.83

69.60

0.66

(3012898) Urea [Moles/volume] in Urine

186

0.94

0.06

1.1

1.3

129.89

155.81

mmol/l

0.67

156

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

103

708

1.02

0.06

1.1

1.07

ratio

0.05

564

(3028308) Erythrocytes [#/volume] in Pleural fluid

397

2819

0.99

0.06

1.4

1.5

74907.71

55656.40

e6/l

0.45

239

1590

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

653

1.02

0.06

1.2

1.3

6.28

6.10

mmol/l

0.62

611

(3021589) Normoblasts [#/volume] in Blood

10729

75335

1.00

0.05

14.9

12.8

0.00

e9/l

2.41

8765

60980

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

118

1.07

0.05

1.1

1.17

1.07

u/field

0.35

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

215

1.05

0.05

1.2

1.1

0.52

0.39

u/ml

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

279

1940

1.01

0.05

1.3

1.2

45.68

58.49

u/ml

0.41

125

(3012441) Differential panel - Pleural fluid

379

2689

0.99

0.05

1.4

1.5

—

0.80

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

441

0.97

0.05

1.9

1.7

11.14

9.61

ug/l

1.30

441

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

177

1227

1.01

0.05

1.2

92.41

97.51

u/l

0.22

153

1035

(3002179) Metamyelocytes/Leukocytes in Blood

2315

16325

1.00

0.05

4.0

4.2

0.74

0.71

0.12

728

5337

(4211845) Urine protein measurement

130

929

0.98

0.05

3.7

3.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

306

2131

1.01

0.05

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

195

1.05

0.04

1.1

—

2.00

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

446

1.02

0.04

2.5

2.3

308.25

612.53

ug/l

0.36

446

(3023199) Leukocytes [#/volume] in Pleural fluid

451

3149

1.01

0.04

1.4

1.5

3616.48

2509.38

e6/l

0.66

324

2216

(3016244) Insulin [Units/volume] in Serum or Plasma

565

1.02

0.04

2.1

2.6

21.98

21.96

mu/l

0.00

524

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

140

1.05

0.04

2.5

1.9

5.46

20.07

4.14

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

147

1.05

0.04

1.1

1.0

97.30

83.71

ug/l

0.50

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

523

3699

0.99

0.04

1.2

1.3

32.65

39.47

u/l

0.70

457

3174

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

227

1580

1.01

0.04

1.1

1.25

1.97

iu/ml

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

134

0.94

0.04

1.0

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

439

0.98

0.04

1.1

1.3

109.90

112.71

0.35

385

(3006462) Nitrate [Presence] in Urine

120

855

0.99

0.03

3.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

322

1.03

0.03

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

427

1.02

0.03

14.5

7.4

5.96

5.46

kpa

0.69

427

(3011335) Digoxin [Mass/volume] in Serum or Plasma

190

1.04

0.03

3.0

2.2

0.66

ug/l

0.01

190

(3021440) Promyelocytes/Leukocytes in Blood

2326

16381

1.00

0.02

4.3

0.11

0.12

0.14

655

4865

(4146454) Self-monitoring of blood glucose

343

2425

0.99

0.02

2.7

2.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

338

0.98

0.02

8.1

6.8

10.33

10.29

0.04

338

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

617

1.01

0.02

1.5

2.2

176.06

171.59

0.17

578

(3024471) HLA-A [Type]

407

1.02

0.02

1.0

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.94

0.02

1.1

1.4

298.67

346.44

umol/24h

0.40

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

175

0.96

0.02

2.4

2.0

61.31

60.81

0.02

114

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

408

0.98

0.02

1.2

105.08

102.87

0.16

378

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

415

0.98

0.02

1.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

157

1113

0.99

0.02

1.4

1.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

106

753

0.99

0.02

1.2

1.3

932.37

192.05

ug/l

1.03

403

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

125

0.96

0.02

1.4

1.3

0.16

0.14

nmol/l

0.10

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

157

1112

0.99

0.02

1.4

1.5

—

(3011985) Renin [Units/volume] in Plasma

370

2611

1.00

0.01

1.4

71.31

59.09

mu/l

0.48

321

2327

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

442

0.99

0.01

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

167

0.97

0.01

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

641

1.01

0.01

1.1

1.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

620

1.01

0.01

38.1

36.2

6.59

7.09

ug/l

1.57

537

(46235168) Fasting glucose [Moles/volume] in Blood

171

1.03

0.01

10.8

1.6

9.11

7.39

mmol/l

1.62

(3045788) Cell count panel - Pleural fluid

361

2533

1.00

0.00

1.3

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

398

0.99

0.00

1.2

80.55

83.98

0.24

208

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

143

1001

1.00

0.00

1.1

1.2

85.00

81.80

0.43

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

133

931

1.00

0.00

4.1

3.3

1.55

1.29

0.63

133

931

(3032743) Legionella sp IgG Ab [Presence] in Serum

137

0.98

0.00

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

123

0.97

0.00

1.7

1.9

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

1.03

0.00

1.1

1.0

0.05

0.03

u/ml

—

(3024932) HLA-DR beta [Type]

391

1.01

0.00

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

291

0.99

0.00

1.2

1.1

15.20

25.36

u/ml

—

(3002079) Sodium [Moles/time] in 24 hour Urine

106

745

1.00

0.00

1.1

1.2

151.75

160.68

mmol/24h

0.47

106

745

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.98

0.00

1.4

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

164

0.99

0.00

1.1

1.0

0.33

2.69

u/ml

0.81

136

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

102

0.96

0.00

4.7

3.5

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.98

0.00

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

404

1.01

0.00

1.2

1.1

79.62

85.40

0.64

205

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

139

977

1.00

0.00

1.5

5.11

6.50

u/l

3.31

119

819

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

17.17

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3045191) Normetanephrine [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

2.52

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

35.00

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

6.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.95

-0.00

1.4

1.1

42.08

33.04

mg/24h

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.98

-0.00

1.4

1.3

1.37

1.26

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.00

-0.00

6.1

6.4

420.38

425.50

umol/l

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

171.60

—

(3018291) Platelet Ab [Presence] in Serum

0.98

-0.00

1.0

—

(3035963) Corticotropin [Moles/volume] in Plasma

0.00

-0.00

0.0

1.0

—

11.32

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: F5_ORGANIC – Organic, including symptomatic, mental disorders

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Organic, including symptomatic, mental disorders

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints